集中治療医学レビュー　2018-'19

出版社： 総合医学社
著者：
発行日： 2018-02-20
分野： 臨床医学：一般  >  集中治療
ISBN： 9784883786596
電子書籍版： 2018-02-20 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

9,900 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

9,900 円(税込)

購入する
特記事項：

商品紹介

最新の集中治療管理に関する14項目、最新の集中治療における検査・技術に関する9項目、最新のICU特有の病態・合併症に関する8項目、最新のトピックスに関する2項目の計33項目の主要文献について解説する。

目次

  • I章　集中治療管理
    　1．神経集中治療
    　2．鎮静・鎮痛・せん妄管理
    　3．呼吸管理（周術期管理を含む）
    　4．循環管理（ショックを含む）
    　5．心臓・大血管術後管理
    　6．消化管管理
    　7．肝胆膵管理
    　8．腎・電解質管理
    　9．内分泌・代謝管理
    　10．血液凝固線溶系管理
    　11．輸血・血漿分画製剤
    　12．感染管理（予防と治療）
    　13．栄養療法（蛋白の時代―高蛋白か低蛋白か？）
    　14．小児集中治療

    II章　集中治療における検査・技術
    　1．集中治療のモニタリング
    　2．カテーテル・ドレーン
    　3．集中治療におけるNPPV
    　4．エコー診断
    　5．補助循環（ECMO，IABP，Impella○R）
    　6．急性血液浄化法
    　7．血液検査・バイオマーカー
    　8．脳低温療法・脳保護療法
    　9．気道確保・気道確保困難症

    III章　ICU特有の病態・合併症
    　1．人工呼吸器関連肺炎
    　2．ARDSの病態と治療
    　3．成人における心肺蘇生と心停止後症候群（Psot-Cardiac Arrest Syndrome）の管理
    　4．心不全の診断と治療
    　5．急性冠症候群の診断と治療
    　6．不整脈の診断と治療
    　7．敗血症の診断と治療
    　8．PICSの病態と治療（ICU-AWを含む）

    IV章　トピックス
    　1．重症度評価・スコアリング
    　2．Rapid Response System

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I章 集中治療管理

P.2 掲載の参考文献
1) Knopf L, Staff I, Gomes J et al:Impact of a neurointensivist on outcomes in critically ill stroke patients. Neurocritical Care. 16:63-71, 2012
PubMed
2) Samuels O, Webb A, Culler S et al:Impact of a dedicated neurocritical care team in treating patients with aneurysmal subarachnoid hemorrhage. Neurocritical Care 14:334-340, 2011
PubMed
3) Egawa S, Hifumi T, Kawakita K et al:Impact of neurointensivist-managed intensive care unit implementation on patient outcomes after aneurysmal subarachnoid hemorrhage. Journal of Critical Care 32:52-55, 2016
PubMed
4) de Oliveira Manoel AL, Mansur A, Silva GS et al:Functional outcome after poorgrade subarachoid hemorrhage:a Single-Center Study and Systematic Literature Review. Neurocritical Care 25:338-350, 2016
 
5) Kramer AH, Zygun DA:Neurocritical care:why does it make a difference? Curr Opin Crit Care 20:174-181, 2014
PubMed
6) Lantigua H, Ortega-Gutierrez S, Schmidt JM et al:Subarachnoid hemorrhage:who dies, and why? Critical Care 19:309, 2015
 
7) Fujii M, Yan J, Rolland WB et al:Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl Stroke Res 4:432-446, 2013
PubMed
8) Savarraj J, Parsha K, Hergenroeder G et al:Early brain injury associated with systemic inflammation after subarachnoid hemorrhage. Neurocritical Care, 2017 Oct 17[Epub ahead of print]
 
9) Aisiku IP, Chen PR, Truong H et al:Admission serum lactate predicts mortality in aneurysmal subarachnoid hemorrhage. The American Journal of Emergency Medicine 34:708-712, 2016
PubMed
10) van Donkelaar CE, Dijkland SA, van den Bergh WM et al:Early circulating lactate and glucose levels after aneurysmal subarachnoid hemorrhage correlate with poor outcome and delayed cerebral ischemia:a two-center cohort study. Crit Care Med, 44:966-972, 2016
PubMed
11) Okazaki T, Hifumi T, Kawakita K et al:Serial blood lactate measurements and its prognostic significance in intensive care unit management of aneurysmal subarachnoid hemorrhage patients. Journal of Critical Care 41:229-233, 2017
PubMed
12) Bales J, Cho S, Tran TK et al:The effect of hyponatremia and sodium variability on outcomes in adults with aneurysmal subarachnoid hemorrhage. World Neurosurg 96:340-349, 2016
PubMed
13) Mapa B, Taylor BE, Appelboom G et al:Impact of hyponatremia on morbidity, mortality, and complications after aneurysmal subarachnoid hemorrhage:a systematic review. World Neurosurg 85:305-314, 2016
PubMed
14) Alimohamadi M, Saghafinia M, Alikhani F, et al:Impact of electrolyte imbalances on the outcome of aneurysmal subarachnoid hemorrhage:a prospective study. Asian J Neurosurg 11:29-33, 2016
PubMed
15) Spatenkova V, Bradac O, de Lacy P et al:Dysnatremia as a poor prognostic indicator in patients with acute subarachnoid hemorrhage. J Neurosurg Sci 61:371-379, 2017
PubMed
16) Sriganesh K, Reddy M, Jena S et al:A comparative study of dexmedetomidine and propofol as sole sedative agents for patients with aneurysmal subarachnoid hemorrhage undergoing diagnosticcerebral angiography. J Anesth 29:409-415, 2015
PubMed
17) Okazaki T, Hifumi T, Kawakita K et al:Association between dexmedetomidine use and neurological outcomes in aneurysmal subarachnoid hemorrhage patients:A retrospective observational study. Journal of Critical Care 44:111-116, 2017
PubMed
18) Maekawa T, Yamashita S, Nagao S et al;Brain-Hypothermia Study G. Prolonged mild therapeutic hypothermia versus fever control with tight hemodynamic monitoring and slow rewarming in patients with severe traumatic brain injury:a randomized controlled trial. Journal of Neurotrauma 32:422-429, 2015
 
19) Suehiro E, Koizumi H, Fujisawa H et al:Diverse effects of hypothermia therapy in patients with severe traumatic brain injury based on the computed tomography classification of the traumatic coma data bank. Journal of Neurotrauma 32:353-358, 2015
PubMed
20) Hifumi T, Kuroda Y, Kawakita K et al:Fever Control Management Is Preferable to Mild Therapeutic Hypothermia in Traumatic Brain Injury Patients with Abbreviated Injury Scale 3-4:A Multi-Center, Randomized Controlled Trial. Journal of Neurotrauma 33:1047-1053, 2016
PubMed
21) Fujita M, Oda Y, Yamashita S et al:Early-stage hyperoxia is associated with favorable neurological outcomes and survival after severe traumatic brain injury:a post-hoc analysis of the brain hypothermia study. Journal of Neurotrauma, 2017 Jan 19[Epub ahead ofprint]
 
22) Kobata H, Sugie A, Suehiro E et al:Association between blood glucose levels the day after targeted temperature initiation and outcome in traumatic brain injury:a post-hoc analysis of the B-HYPO study. Journal of Neurotrauma 34:987-995, 2017
 
23) Carney N, Totten AM, O'Reilly C et al:Guidelines for the management of severe traumatic brain injury, Fourth Edition. Neurosurgery 80:6-15, 2017.
PubMed
24) Suehiro E, FujiyamaY, Koizumi H et al:Directions for use of intracranial pressure monitoring in treatment of severe traumatic brain injury using data from the Japan Neurotrauma Data Bank. Journal of Neurotrauma, 2017 Mar 23[Epub ahead of print]
 
25) Okonkwo DO, Shutter LA, Moore C et al:Brain oxygen optimization in severe traumatic brain injury phase-II:a phase II randomized trial. Crit Care Med 45:1907-1914, 2017
 
26) Mangat HS, Chiu YL, Gerber LM et al:Hypertonic saline reduces cumulative and daily intracranial pressure burdens after severe traumatic brain injury. Journal of Neurosurgery 122:202-210, 2015
PubMed
27) Andrews PJ, Sinclair HL, Rodriguez A et al:Hypothermia for intracranial hypertension after traumatic brain injury. N Engl J Med 373:2403-2412, 2015.
PubMed
28) Rizoli SB, Jaja BN, Di Battista AP et al:Catecholamines as outcome markers in isolated traumatic brain injury:the COMATBI study. Critical Care 21:37, 2017
 
29) Hutchinson PJ, Kolias AG, Timofeev IS et al:Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med 375:1119-1130, 2016
PubMed
30) Iacobone E, Bailly-Salin J, Polito A et al:Sepsis-associated encephalopathy and its differential diagnosis. Crit Care Med 37:S331-336, 2009
PubMed
31) Oddo M, Taccone FS:How to monitor the brain in septic patients? Minerva Anestesiol 81:776-788, 2015
PubMed
32) Hosokawa K, Gaspard N, Su F et al:Clinical neurophysiological assessment of sepsis-associated brain dysfunction:a systematic review. Critical Care 18:674, 2014
PubMed
33) Reznik ME, Merkler AE, Mahta A et al:Long-term risk of seizures in adult survivors of sepsis. Neurology 89:1476-1482, 2017
PubMed
34) Kubota Y, Nakamoto H, Kawamata T:Nonconvulsive status epilepticus in the neurosurgical setting. Neurol Med Chir(Tokyo) 56:626-631, 2016
PubMed
35) Egawa S, Hifumi T, Kawakita K et al:Clinical characteristics of non-convulsive status epilepticus diagnosed by simplified continuous electroencephalogram monitoring at an emergency intensive care unit. Acute Med Surg 4:31-37, 2017
PubMed
36) Berisavac, II, Padjen VV, Ercegovac MD et al:Focal epileptic seizures, electroencephalography and outcome of sepsis associated encephalopathy-a pilot study. Clin Neurol Neurosurg 148:60-66, 2016
PubMed
37) Polito A, Eischwald F, Maho AL et al:Pattern of brain injury in the acute setting of human septic shock. Critical Care 17:R204, 2013
 
38) Ehler J, Barrett LK, Taylor V et al:Translational evidence for two distinct patterns of neuroaxonal injury in sepsis:a longitudinal, prospective translational study. Critical Care 21:262, 2017
 
P.8 掲載の参考文献
1) Minhas MA, Velasquez AG, Kaul A et al:Effect of protocolized sedation on clinical outcomes in mechanically ventilated intensive care unit patients:a systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc 90:613-623, 2015
PubMed
2) Faust AC, Rajan P, Sheperd LA et al:Impact of an analgesia-based sedation protocol on mechanically ventilated patients in a medical intensive care unit. Anesth Analg 123:903-909, 2016
 
3) Kanji S, MacPhee H, Singh A et al:Validation of the critical care pain observation tool in critically ill patients with delirium:a prospective cohort study. Crit Care Med 44:943-947, 2016
PubMed
4) Djaiani G, Silverton N, Fedorko L et al:Dexmedetomidine versus propofol sedation reduces delirium after cardiac surgery:a randomized controlled trial. Anesthesiology 124:362-368, 2016
PubMed
5) Su X, Meng ZT, Wu XH et al:Dexmedetomidine for prevention of delirium in elderly patients after noncardiac surgery:a randomised, doubleblind, placebo-controlled trial. Lancet 388:1893-1902, 2016
 
6) Zamani MM, Keshavarz-Fathi M, Fakhri-Bafghi MS et al:Survival benefits of dexmedetomidine used for sedating septic patients in intensive care setting:a systematic review. J Crit Care 32:93-100, 2016
PubMed
7) Kawazoe Y, Miyamoto K, Morimoto T et al:Dexmedetomidine for sepsis in intensive care unit randomized evaluation(DESIRE) trial investigators:effect of dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with sepsis:a randomized clinical trial. JAMA 317:1321-1328, 2017
 
8) Zhang Z, Chen K, Ni H et al:Sedation of mechanically ventilated adults in intensive care unit:a network meta-analysis. Sci Rep 7:44979, 2017
 
9) Lingehall HC, Smulter NS, Lindahl E et al:Preoperative cognitive performance and postoperative delirium are independently associated with future dementia in older people who have undergone cardiac surgery:a longitudinal cohort study. Crit Care Med 45:1295-1303, 2017
PubMed
10) Luetz A, Weiss B, Boettcher S et al:Routine delirium monitoring is independently associated with a reduction of hospital mortality in critically ill surgical patients:a prospective, observational cohort study. J Crit Care 35:168-173, 2016
PubMed
11) Zaal IJ, Devlin JW, Hazelbag M et al:Benzodiazepine-associated delirium in critically ill adults. Intensive Care Med 41:2130-2137, 2015
PubMed
12) Khan BA, Perkins AJ, Gao S, Hui SL et al:The confusion assessment method for the ICU-7 delirium severity scale:a novel delirium severity instrument for use in the ICU. Crit Care Med 45:851-857, 2017
 
13) Neufeld KJ, Yue J, Robinson TN et al:Antipsychotic medication for prevention and treatment of delirium in hospitalized adults:a systematic review and metaanalysis. J Am Geriatr Soc 64:705-714, 2016
PubMed
14) Serafim RB, Bozza FA, Soares M et al:Pharmacologic prevention and treatment of delirium in intensive care patients:A systematic review. J Crit Care 30:799-807, 2015
PubMed
15) Marshall J, Herzig SJ, Howell MD et al:Antipsychotic utilization in the intensive care unit and in transitions of care. J Crit Care 33:119-124, 2016
 
16) Tomichek JE, Stollings JL, Pandharipande PP et al:Antipsychotic prescribing patterns during and after critical illness:a prospective cohort study. Crit Care 20:378, 2016
PubMed
17) Jolley SE, Moss M, Needham DM et al;Acute Respiratory Distress Syndrome Network Investigators:point prevalence study of mobilization practices for acute respiratory failure patients in the United States. Crit Care Med 45:205-215, 2017
PubMed
18) Litton E, Carnegie V, Elliott R et al:The efficacy of earplugs as a sleep hygiene strategy for reducing delirium in the ICU:a systematic review and metaanalysis. Crit Care Med 44:992-999, 2016
PubMed
19) Hu RF, Jiang XY, Chen J et al:Nonpharmacological interventions for sleep promotion in the intensive care unit. Cochrane Database Syst Rev 10:CD008808, 2015
PubMed
20) Flannery AH, Oyler DR, Weinhouse GL:The impact of interventions to improve sleep on delirium in the ICU:a systematic review and research framework. Crit Care Med 44:2231-2240, 2016
PubMed
21) Rivosecchi RM, Kane-Gill SL, Svec S et al:The implementation of a nonpharmacologic protocol to prevent intensive care delirium. J Crit Care 31:206-211, 2016
PubMed
22) Miller MA, Govindan S, Watson SR et al:ABCDE, but in that order? a crosssectional survey of Michigan intensive care unit sedation, delirium, and early mobility practices. Ann Am Thorac Soc 12:1066-1071, 2015
 
23) Barnes-Daly MA, Phillips G, Ely EW:Improving hospital survival and reducing brain dysfunction at seven california community hospitals:implementing PAD guidelines via the ABCDEF bundle in6,064 patients. Crit Care Med 45:171-178, 2017
 
24) Ely EW:The ABCDEF bundle:science and philosophy of how ICU liberation serves patients and families. Crit Care Med 45:321-330, 2017
PubMed
25) DAS-Taskforce 2015, Baron R, Binder A, Biniek R et al:Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015(DAS-Guideline 2015)-short version. Ger Med Sci 13:Doc19, 2015
PubMed
26) Romagnoli S, Chelazzi C, Villa G et al:The new MIRUS system for short-term sedation in postsurgical ICU patients. Crit Care Med 45:e925-e931, 2017
PubMed
27) Vincent JL, Shehabi Y, Walsh TS et al:Comfort and patient-centred care without excessive sedation:the eCASH concept. Intensive Care Med 42:962-971, 2016
PubMed
P.18 掲載の参考文献
1) Serpa Neto A, Hemmes SN, Barbas CS et al:Protective versus conventional ventilation for surgery:a systematic review and individual patient data metaanalysis. Anesthesiology 123:66-78, 2015
PubMed
2) Neto AS, Hemmes SN, Barbas CS et al:Association between driving pressure and development of postoperative pulmonary complications in patients undergoingmechanical ventilation for general anaesthesia:a meta-analysis of individual patient data. Lancet Respir Med 4:272-280, 2016
PubMed
3) Neto AS, Simonis FD, Barbas CS et al:Lung-protective ventilation with low tidal volumes and the occurrence of pulmonary complications in patients without acute respiratory distress syndrome:a systematicreview and individual patient data analysis. Crit Care Med 43:2155-2163, 2015
 
4) Bellani G, Laffey JG, Pham T et al:Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 conutries. JAMA 315:788-800, 2016
 
5) Lim J, Litton E, Robinson H et al:Characteristics and outcomes of patients treated with airway pressure release ventilation for acute respiratory distress syndrome:a retrospective observational study. J Crit Care 34:154-159, 2016
PubMed
6) Sud S, Sud M, Friedrich JO et al:High-frequency oscillatory ventilation versus conventional ventilation for acute respiratory distress syndrome. Cochrane Database Syst Rev 4:CD004085, 2016
PubMed
7) Meduri GU, Bridges L, Shih MC et al:Prolonged glucocorticoid treatment is associated with inproved ARDS outcomes:analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med 42:829-840, 2016
 
8) Fanelli V, Ranieri MV, Mancebo J et al:Feasibility and safety of low-flow extracorporeal carbon dioxide removal to facilitate ultra-protective ventilation in patients with moderate acute respiratory distress syndrome. Crit Care 20:36, 2016
PubMed
9) Ayzac L, Girard R, Baboi L et al:Ventilator-associated pneumonia in ARDS patients:the impact of prone positioning. a secondary analysis of the PROSEVA trial. Intensive Care Med 42:871-878, 2016
 
10) Tusman G, Acosta CM, Nicola M et al:Real-time images of tidal recruitment using lung ultrasound. Crit Ultrasoud J 7:19, 2015
 
11) Jung B, Moury PH, Mahul M et al:Diaphragmatic dysfunction in patients with ICU-acquired weakness and its impact on extubation failure. Intensive Care Med 42:853-861, 2016
PubMed
12) Cherpanath TG, Smeding L, Hirsch A et al:Low tidal volume ventilation ameliorates left ventricular dysfunction in mechanically ventilated rats following LPS-induced lung injury. BMC Anesthesiol 15:140, 2015
PubMed
13) Schirmer-Mikalsen K, Vik A, Skogvoll E et al:Intracranial pressure during pressure control and pressure-regulated volume control ventilation in patients with traumatic brain injury:a randomized crossover trial. Neurocrit Care 24:332-341, 2016
PubMed
14) Nasef N, El-Gouhary E, Schurr P et al:High-flow nasal cannulae are associated with increased diaphragm activation compared with nasal continuous positive airway pressure in preterm infants. Acta Paediatr 104:e337-343, 2015
PubMed
15) Meeder AM, Tjan DH, van Zanten AR et al:Noninvasive and invasive positive pressure ventilation for acute respiratory failure in critically ill patients:a comparative cohort study. J Thorac Dis 8:813-825, 2016
PubMed
16) Lemiale V, Mokart D, Resche-Rigon M et al:Effect of noninvasive ventilation vs oxygen therapy on mortality among lmmunocompromised patients with acute respiratory failure:a randomized clinical trial. JAMA 314:1711-1719, 2015
PubMed
17) Muriel A, Penuelas O, Frutos-Vivar F et al:Impact of sedation and analgesia during noninvasive positive pressure ventilation on outcome:a marginal structural model causal analysis. Intensive Care Med 41:1586-1600, 2015
PubMed
18) Zhu B, Li Z, Jiang L et al:Effect of a quality improvement program on weaning from mechanical ventilation:a cluster randomized trial. Intensive Care Med 41:1781-1790, 2015
 
19) Haugdahl HS, Storli SL, Meland B et al:Underestimation of patient breathlessness by nurses and physicians during a spontaneous breathing trial. Am J Respir Crit Care Med 192:1440-1448, 2015
PubMed
20) Kimura F:Tracheostomy and invasive mechanical ventilation in amyotrophic lateral sclerosis:decision-making factors and survival analysis. Rinsho Shinkeigaku 56:241-247, 2016
PubMed
21) Fujiwara Y, Yamaguchi H, Kobayashi K et al:The therapeutic outcomes of mechanical ventilation in hematological malignancy patients with respiratory failure. Intern Med 55:1537-1545, 2016
PubMed
22) Reed K, Pengo MF, Steier J:Screening for sleep-disordered breathing in a bariatric population. J Thorac Dis 8:268-275, 2016
 
P.25 掲載の参考文献
1) 西田修, 小倉裕司, 井上茂亮 他:日本版敗血症診療ガイドライン2016:The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016(J-SSCG2016). 日集中医誌24:s1-s232, 2016
 
2) Cecconi M, Hofer C, Teboul JL et al:Fluid challenges in intensive care:the FENICE study:a global inception cohort study. Intensive Care Med 41:1529-1537, 2015
PubMed
3) Preau S, Bortolotti P, Colling D et al:Diagnostic accuracy of the inferior vena cava collapsibility to predict fluid responsiveness in spontaneously breathing patients with sepsis and acute circulatory failure. Crit Care Med 45:e290-e297, 2017
PubMed
4) Vignon P, Repesse X, Begot E et al:Comparison of echocardiographic indices used to predict fluid responsiveness in ventilated patients. Am J Respir Crit Care Med 195:1022-1032, 2017
PubMed
5) Michard F, Pinsky MR, Vincent JL:Intensive care medicine in 2050:NEWS for hemodynamic monitoring. Intensive Care Med 43:440-442, 2017
PubMed
6) Toscani L, Aya HD, Antonakaki D etal:What is the impact of the fluid challenge technique on diagnosis of fluid responsiveness? a systematic review and meta-analysis. Crit Care 21:207, 2017
PubMed
7) Gamper G, Havel C, Arrich J et al:Vasopressors for hypotensive shock. Cochrane Database Syst Rev 2:Cd003709, 2016
PubMed
8) 日本蘇生協議会:JRC蘇生ガイドライン2015オンライン版第2章成人の二次救命処置(ALS). http://www.japanresuscitationcouncil.org/wp-content/uploads/2016/04/0e5445d84c8c2a31aaa17db0a9c67b76.pdf
 
9) Chawla LS, Russell JA, Bagshaw SM et al:Angiotensin II for the Treatment of High-Output Shock 3(ATHOS-3):protocol for a phase III, double-blind, randomised controlled trial. Crit Care Resusc 19:43-49, 2017
 
10) Khanna A, English SW, Wang XS et al:Angiotensin II for the treatment of vasodilatory shock. N Engl J Med 377:419-430, 2017
 
11) Lamontagne F, Cook DJ, Meade MO et al:Vasopressor use for severe hypotension-A multicentre prospective observational study. PLoS One 12:e0167840, 2017
PubMed
12) Lamontagne F, Meade MO, Hebert PC et al:Higher versus lower blood pressure targets for vasopressor therapy in shock:a multicentre pilot randomized controlled trial. Intensive Care Med 42:542-550, 2016
 
13) D'Aragon F, Belley-Cote EP, Meade MO et al:Blood pressure targets for vasopressor therapy:a systematic review. Shock 43:530-539, 2015
PubMed
14) Osawa EA, Rhodes A, Landoni G et al:Effect of perioperative goal-directed hemodynamic resuscitation therapy on outcomes following cardiac surgery:a randomized clinical trial and systematic review. Crit Care Med 44:724-733, 2016
 
15) Kapoor PM, Magoon R, Rawat R et al:Perioperative utility of goal-directed therapy in high-risk cardiac patients undergoing coronary artery bypass grafting:"a clinical outcome and biomarker-based study". Ann Card Anaesth 19:638-682, 2016
 
16) Malbouisson LMS, Silva JM, Jr., Carmona MJC et al:A pragmatic multi-center trial of goal-directed fluid management based on pulse pressure variation monitoring during high-risk surgery. BMC Anesthesiol 17:70, 2017
PubMed
17) Li P, Qu LP, Qi D et al:Significance of perioperative goal-directed hemodynamic approach in preventing postoperative complications in patients after cardiac surgery:a meta-analysis and systematic review. Ann Med 49:343-351, 2017
PubMed
18) Khera R, Pandey A, Kumar N et al:Variation in hospital use and outcomes associated with pulmonary artery catheterization in heart failure in the United States. Circ Heart Fail 9, 2016
 
19) Rossello X, Vila M, Rivas-Lasarte M et al:Impact of pulmonary artery catheter use on short- and long-term mortality in patients with cardiogenic shock. Cardiology 136:61-69, 2017
 
20) Unverzagt S, Buerke M, de Waha A et al:Intra-aortic balloon pump counterpulsation(IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev Cd007398, 2015
PubMed
21) Zheng XY, Wang Y, Chen Y et al:The effectiveness of intra-aortic balloon pump for myocardial infarction in patients with or without cardiogenic shock:a meta-analysis and systematic review. BMC Cardiovasc Disord 16:148, 2016
PubMed
22) Miller PE, Solomon MA, McAreavey D:Advanced percutaneous mechanical circulatory support devices for cardiogenic shock. Crit Care Med 45:1922-1929. 2017
PubMed
23) Ouweneel DM, Eriksen E, Sjauw KD et al:Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 69:278-287, 2017
PubMed
24) Schroeter MR, Kohler H, Wachter A et al:Use of the Impella device for acute coronary syndrome complicated by cardiogenic shock-experience from a single heart center with analysis of long-term mortality. J Invasive Cardiol 28:467-472, 2016
PubMed
25) Basir MB, Schreiber TL, Grines CL et al:Effect of early initiation of mechanical circulatory support on survival in cardiogenic shock. Am J Cardiol 119:845-851, 2017
PubMed
26) Packer M, O'Connor C, McMurray JJV et al:Effect of ularitide on cardiovascular mortality in acute heart failure. N Engl J Med 376:1956-1964, 2017
PubMed
27) Mebazaa A, Tolppanen H, Mueller C et al:Acute heart failure and cardiogenic shock:a multidisciplinary practical guidance. Intensive Care Med 42:147-163, 2016
PubMed
28) Matsue Y, Damman K, Voors AA et al:Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure. J Am Coll Cardiol 69:3042-3051, 2017
PubMed
29) Martindale JL, Wakai A, Collins SP et al:Diagnosing acute heart failure in the emergency department:a systematic review and meta-analysis. Acad Emerg Med 23:223-242, 2016
PubMed
30) Lichtenstein DA:BLUE-protocol and FALLS-protocol:two applications of lung ultrasound in the critically ill. Chest 147:1659-1670, 2015
PubMed
P.32 掲載の参考文献
1) Osawa EA, Rhodes A, Landoni G et al:Effect of perioperative goal-directed hemodynamic resuscitation therapy on outcomes following cardiac surgery:a randomized clinical trial and systematic review. Crit Care Med 44:724-733, 2016
 
2) Kapoor PM, Magoon R, Rawat R et al:Perioperative utility of goal-directed therapy in high-risk cardiac patients undergoing coronary artery bypass grafting:"a clinical outcome and biomarker-based study". Ann Card Anaesth 19:638-682, 2016
 
3) Kapoor PM, Magoon R, Rawat RS et al:Goal-directed therapy improves the outcome of high-risk cardiac patients undergoing off-pump coronary artery bypass. Ann Card Anaesth 20:83-89, 2017
PubMed
4) Li P, Qu LP, Qi D et al:Significance of perioperative goal-directed hemodynamic approach in preventing postoperative complications in patients after cardiac surgery:a meta-analysis and systematic review. Ann Med 49:343-351, 2017
PubMed
5) Magruder JT, Crawford TC, Harness HL et al:A pilot goal-directed perfusion initiative is associated with less acute kidney injury after cardiac surgery. J Thorac Cardiovasc Surg 153:118-125, 2017
PubMed
6) Myles PS, Smith JA, Forbes A et al:Stopping vs. continuing aspirin before coronary artery surgery. N Engl J Med 374:728-737, 2016
PubMed
7) Lee J, Jung CW, Jeon Y et al:Effects of preoperative aspirin on perioperative platelet activation and dysfunction in patients undergoing off-pump coronary artery bypass graft surgery:a prospective randomized study. PLoS One 12:e0180466, 2017
 
8) Myles PS, Smith JA, Forbes A et al:Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med 376:136-148, 2017
PubMed
9) Ranucci M, Baryshnikova E, Ranucci M et al:Fibrinogen levels compensation of thrombocytopenia-induced bleeding following cardiac surgery. Int J Cardiol 249:96-100, 2017
PubMed
10) Kievisas M, Keturakis V, Vaitiekunas E et al:Prognostic factors of atrial fibrillation following coronary artery bypass graft surgery. Gen Thorac Cardiovasc Surg 65:566-574, 2017
PubMed
11) Vlahou A, Diplaris K, Ampatzidou F et al:The role of blood transfusion in the development of atrial fibrillation after coronary artery bypass grafting. Thorac Cardiovasc Surg 64:688-692, 2016
PubMed
12) Gillinov AM, Bagiella E, Moskowitz AJ et al:Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N Engl J Med 374:1911-1921, 2016
PubMed
13) Tamura T, Yatabe T, Yokoyama M:Prevention of atrial fibrillation after cardiac surgery using low-dose landiolol:a systematic review and meta-analysis. J Clin Anesth 42:1-6, 2017
PubMed
14) Legouis D, Galichon P, Bataille A et al:Rapid occurrence of chronic kidney disease in patients experiencing reversible acute kidney injury after cardiac surgery. Anesthesiology 126:39-46, 2017
PubMed
15) Helgadottir S, Sigurdsson MI, Palsson R et al:Renal recovery and long-term survival following acute kidney injury after coronary artery surgery:a nationwide study. Acta Anaesthesiol Scand 60:1230-1240, 2016
PubMed
16) Wu B, Sun J, Liu S et al:Relationship among mortality of patients with acute kidney injury after cardiac surgery, fluid balance and ultrafiltration of renal replacement therapy:an observational study. Blood Purif 44:32-39, 2017
PubMed
17) Haase-Fielitz A, Haase M, Bellomo R et al:Perioperative hemodynamic instability and fluid overload are associated with increasing acute kidney injury severity and worse outcome after cardiac surgery. Blood Purif 43:298-308, 2017
PubMed
18) Momeni M, Nkoy Ena L, Van Dyck M et al:The dose of hydroxyethyl starch 6% 130/0.4 for fluid therapy and the incidence of acute kidney injury after cardiac surgery:a retrospective matched study. PLoS One 12:e0186403, 2017
 
19) Yamada M, Nishi H, Sekiya N et al:The efficacy of tolvaptan in the perioperative management of chronic kidney disease patients undergoing open-heart surgery. Surg Today 47:498-505, 2017
PubMed
20) Ito H, Mizumoto T, Tempaku H et al:Efficacy of tolvaptan on fluid management after cardiovascular surgery using cardiopulmonary bypass. J Cardiothorac Vasc Anesth 30:1471-1478, 2016
PubMed
21) Matsuyama K, Koizumi N, Nishibe T et al:Effects of short-term administration of tolvaptan after open heart surgery. Int J Cardiol 220:192-195, 2016
PubMed
22) Kato TS, Nakamura H, Murata M et al:The effect of tolvaptan on renal excretion of electrolytes and urea nitrogen in patients undergoing coronary artery bypass surgery. BMC Cardiovasc Disord 16:181, 2016
PubMed
23) Kono T, Tayama E, Hori H et al:A safety and efficacy study of tolvaptan following open heart surgery in 109 cases. Int Heart J 57:496-502, 2016.
PubMed
24) Soh S, Song JW, Shim JK et al:Sodium bicarbonate does not prevent postoperative acute kidney injury after off-pump coronary revascularization:a doubleblinded randomized controlled trial. Br J Anaesth 117:450-457, 2016
 
25) Mei M, Zhao HW, Pan QG et al:Efficacy of N-acetylcysteine in preventing acute kidney injury after cardiac surgery:a meta-analysis study. J Invest Surg 6:1-10, 2017
 
26) Zheng Z, Jayaram R, Jiang L et al:Perioperative rosuvastatin in cardiac surgery. N Engl J Med 374:1744-1753, 2016
PubMed
27) Billings FT 4th, Hendricks PA, Schildcrout JS et al:High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery:a randomized clinical Trial. JAMA 315:877-888, 2016
PubMed
28) Yuan X, Du J, Liu Q et al:Defining the role of perioperative statin treatment in patients after cardiac surgery:a meta-analysis and systematic review of 20 randomized controlled trials. Int J Cardiol 228:958-966, 2017
PubMed
29) Xiong B, Nie D, Cao Y et al:Preoperative statin treatment for the prevention of acute kidney injury in patients undergoing cardiac surgery:a meta-analysis of randomised controlled trials. Heart Lung Circ 26:1200-1207, 2017
PubMed
30) Meersch M, Schmidt C, Hoffmeier A et al:Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers:the PrevAKI randomized controlled trial. Intensive Care Med 43:1551-1561, 2017
PubMed
P.38 掲載の参考文献
1) Rhodes A, Evans LE, Alhazzani W et al:Surviving Sepsis Campaign:International Guidelines for Management of Sepsis and Septic Shock:2016. Intensive Care Med 43:304-377, 2017
PubMed
2) Selvanderan SP, Summers MJ, Finnis ME et al:Pantoprazole or placebo for stress ulcer prophylaxis(POP-UP):randomized double-blind exploratory study. Crit Care Med 44:1842-1850, 2016
PubMed
3) Alhazzani W, Guyatt G, Alshahrani M et al:Withholding pantoprazole for stress ulcer prophylaxis in critically ill patients:a pilot randomized clinical trial and metaanalysis. Crit Care Med 45:1121-1129, 2017
PubMed
4) Alshamsi F, Belley-Cote E, Cook D et al:Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients:a systematic review and meta-analysis of randomized trials. Crit Care 20:120, 2016
PubMed
5) Faleck DM, Salmasian H, Furuya EY et al:Proton pump inhibitors do not increase risk for clostridium difficile infection in the intensive care unit. Am J Gastroenterol 111:1641-1648, 2016
 
6) Sasabuchi Y, Matsui H, Lefor AK et al:Risks and benefits of stress ulcer prophylaxis for patients with severe sepsis. Crit Care Med 44:e464-469, 2016
PubMed
7) Cohen ME, Hathway JM, Salmasian H et al:Prophylaxis for stress ulcers with proton pump inhibitors is not associated with increased risk of bloodstream infections in the intensive care unit. Clin Gastroenterol Hepatol 15:1030-1036.e1031, 2017
PubMed
8) Marker S, Krag M, Moller MH:What's new with stress ulcer prophylaxis in the ICU? Intensive Care Med 43:1132-1134, 2017
 
9) Tan B, Norman R, Litton E et al:Incidence and cost of stress ulcer prophylaxis after discharge from the intensive care unit:a retrospective study. Crit Care Resusc 18:270-274, 2016
PubMed
10) Li H, Zhang D, Wang Y et al:Association between acute gastrointestinal injury grading system and disease severity and prognosis in critically ill patients:a multicenter, prospective, observational study in China. J Crit Care 36:24-28, 2016
 
11) Hu B, Sun R, Wu A et al:Severity of acute gastrointestinal injury grade is a predictor of all-cause mortality in critically ill patients:a multicenter, prospective, observational study. Crit Care 21:188, 2017
PubMed
12) Zhang D, Fu R, Li Y et al:Comparison of the clinical characteristics and prognosis of primary versus secondary acute gastrointestinal injury in critically ill patients. J Intensive Care 5:26, 2017
 
13) Lynch SV, Pedersen O:The human intestinal microbiome in health and disease. N Engl J Med 375:2369-2379, 2016
PubMed
14) Morrow LE, Wischmeyer P:Blurred lines:dysbiosis and probiotics in the ICU. Chest 151:492-499, 2017
PubMed
15) Kitsios GD, Morowitz MJ, Dickson RP et al:Dysbiosis in the intensive care unit:microbiome science coming to the bedside. J Crit Care 38:84-91, 2017
 
16) Lankelma JM, van Vught LA, Belzer Cet al:Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation:a pilot study. Intensive Care Med 43:59-68, 2017
 
17) Ojima M, Motooka D, Shimizu K et al:Metagenomic analysis reveals dynamic changes of whole gut microbiota in the acute phase of intensive care unit patients. Dig Dis Sci 61:1628-1634, 2016
PubMed
18) Jackson MA, Goodrich JK, Maxan ME et al:Proton pump inhibitors alter the composition of the gut microbiota. Gut 65:749-756, 2016
PubMed
19) Wei Y, Yang J, Wang J et al:Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis. Crit Care 20:332, 2016
 
20) Wurm P, Spindelboeck W, Krause R et al:Antibiotic-associated apoptotic enterocolitis in the absence of a defined pathogen:the role of intestinal microbiota depletion. Crit Care Med 45:e600-e606, 2017
PubMed
21) Bafeta A, Yavchitz A, Riveros C et al:Methods and reporting studies assessing fecal microbiota transplantation:a systematic review. Ann Intern Med 167:34-39, 2017
PubMed
22) Lee CH, Steiner T, Petrof EO et al:Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent clostridium difficile infection:a randomized clinical trial. JAMA 315:142-149, 2016
PubMed
23) Ott SJ, Waetzig GH, Rehman A et al:Efficacy of sterile fecal filtrate transfer for treating patients with clostridium difficile infection. Gastroenterology 152:799-811.e7, 2017
 
24) Zeng J, Wang CT, Zhang FS et al:Effect of probiotics on the incidence of ventilatorassociated pneumonia in critically ill patients:a randomized controlled multicenter trial. Intensive Care Med 42:1018-1028, 2016
 
25) Manzanares W, Lemieux M, Langlois PL et al:Probiotic and synbiotic therapy in critical illness:a systematic review and meta-analysis. Crit Care 19:262, 2016
 
26) Cook DJ, Johnstone J, Marshall JC et al:Probiotics:prevention of severe pneumonia and endotracheal colonization trial-PROSPECT:a pilot trial. Trials 17:377, 2016
PubMed
27) Santacruz CA, Quintairos A, Righy C et al:Is there a role for enterohormones in the gastroparesis of critically ill patients? Crit Care Med 45:1696-1701, 2017
 
28) Lewis K, Alqahtani Z, Mcintyre L et al:The efficacy and safety of prokinetic agents in critically ill patients receiving enteral nutrition:a systematic review and meta-analysis of randomized trials. Crit Care 20:259, 2016
PubMed
29) Treskes N, Persoon AM, van Zanten ARH:Diagnostic accuracy of novel serological biomarkers to detect acute mesenteric ischemia:a systematic review and meta-analysis. Intern Emerg Med 2017[Epub ahead of print]
 
30) Clair DG, Beach JM:Mesenteric Ischemia. N Engl J Med 374:959-968, 2016
PubMed
31) Sekino M, Funaoka H, Sato S et al:Intestinal fatty acid-binding protein level as a predictor of 28-day mortality and bowel ischemia in patients with septic shock:a preliminary study. J Crit Care 42:92-100, 2017
PubMed
P.44 掲載の参考文献
1) 持田 智:急性肝不全-概念, 診断基準とわが国における実態-. 日消誌 112:813-821, 2015
Medical*Online
2) 持田 智:急性肝不全:わが国における課題. 肝臓 56:453-460, 2015
 
3) Fujiwara K, Yokosuka O, Inoue K et al:Distribution of core hospitals for patients with fulminant hepatitis and late onset hepatic failure in Japan. Hepatol Res 46:10-12, 2016
PubMed
4) Fujiwara K, Yasui S, Yonemitsu Y et al:Importance of the poor prognosis of severe and fulminant hepatitis in the elderly in an era of a highly aging society:analysis in a Japanese center. Hepatol Res 45:863-871, 2015
 
5) Peng Y, Qi X, Guo X:Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis:a systematic review and meta-analysis of observational studies. Medicine 95:e2877, 2016
 
6) Sato M, Tateishi R, Yasunaga H:Variceal hemorrhage:analysis of 9987 cases from a Japanese nationwide database. Hepatol Res 45:288-93, 2015
PubMed
7) Larsen FS, Schmidt LE, Bernsmeier C et al:High-volume plasma exchange in patients with acute liver failure:an open randomised controlled trial. J Hepatol 64:69-78, 2016
PubMed
8) Hu J1, Zhang Q2, Ren X et al:Efficacy and safety of acetylcysteine in "nonacetaminophen" acute liver failure:a meta-analysis of prospective clinical trials. Clin Res Hepatol Gastroenterol 39:594-599, 2015
 
9) Swaid F, Peleg K, Alfici R et al:The severity of liver injury following blunt trauma does not correlate with the number of fractured ribs:an analysis of a national trauma registry database. Surg Today 45:846-850, 2015
PubMed
10) 熊田 卓:こむら返りに対する芍薬甘草湯の効果. 漢方と最新治療 25:91-95, 2016
 
11) Takada T, Strasberg SM, Solomkin JS et al:TG13:Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 20:1-7, 2013
 
12) Kiriyama S, Takada T, Strasberg SM et al:TG13 guidelines for diagnosis and severity grading of acute cholangitis. J Hepatobiliary Pancreat Sci 20:24-34, 2013
PubMed
13) Yokoe M, Takada T, Strasberg SM et al:TG13 diagnostic criteria and severity grading of acute cholecystitis. J Hepatobiliary Pancreat Sci 20:35-46, 2013
 
14) Miura F, Takada T, Strasberg SM et al:TG13 flowchart for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 20:47-54, 2013
PubMed
15) Okamoto K, Takada T, Strasberg SM et al:TG13 management bundles for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 20:55-59, 2013
PubMed
16) Yokoe M, Takada T, Hwang TL et al:Descriptive review of acute cholecystitis:Japan-Taiwan collaborative epidemiological study. J Hepatobiliary Pancreat Sci 24:319-328, 2017
PubMed
17) Endo I, Takada T, Hwang TL et al:Optimal treatment strategy for acute cholecystitis based on predictive factors:Japan-Taiwan multicenter cohort study. J Hepatobiliary Pancreat Sci 24:346-361, 2017
PubMed
18) Paul Wright G, Stilwell K, Johnson J et al:Predicting length of stay andconversion to open cholecystectomy for acute cholecystitis using the 2013 Tokyo Guidelines in a US population. J Hepatobiliary Pancreat Sci 22:795-801, 2015
 
19) Bouassida M, Charrada H, Feidi B et al:Could the Tokyo Guidelines on the management of acute cholecystitis be adopted in developing countries? experience of one center. Surg Today. 46:557-560, 2016
PubMed
20) 永岡智之, 渡邊常太, 中川祐輔 他:腹腔鏡下急性胆嚢炎手術における術後合併症危険因子についての検討. 日臨外会誌 77:739-745, 2016
 
21) 吉本匡志, 日置勝義, 大川 広 他:抗血栓薬内服症例に対する緊急腹腔鏡下胆嚢摘出術. 日内視外会誌 22:199-205, 2017
 
22) 藤本直己, 淺井 哲, 竹下宏太郎 他:Updated Tokyo Guidelinesに基づいた重症度別の急性胆管炎に対する内視鏡的胆道ドレナージのタイミングの検討. 日腹救医会誌 36:863-868, 2016
 
23) Chaari A, Abdel Hakim K, Bousselmi K et al:Pancreatic injury in patients with septic shock:a literature review. World J Gastrointest Oncol 8:526-531, 2016
PubMed
24) Gomatos IP, Halloran CM, Ghaneh P et al:Outcomes from minimal access retroperitoneal and open pancreatic necrosectomy in 394 patients with necrotizing pancreatitis. Ann Surg 263:992-1001, 2016
PubMed
25) Hamada T, Yasunaga H, Nakai Y et al:No weekend effect on outcomes of severe acute pancreatitis in Japan:data from the diagnosis procedure combination database. J Gastroenterol 51:1063-1072, 2016
PubMed
P.51 掲載の参考文献
1) AKI(急性腎障害)診療ガイドライン作成委員会:AKI(急性腎障害)診療ガイドライン2016. 東京医学社, 2016
 
2) 厚生労働省科学研究費補助金平成27年度日本医療開発機構腎疾患実用化研究事業「慢性腎臓病の進行を促進する薬剤等による腎障害の早期診断法と治療法の開発」薬剤性腎障害の診療ガイドライン作成委員会:薬剤性腎障害診療ガイドライン2016. 日腎会誌 58:477-555, 2016
 
3) 日本版敗血症診療ガイドライン2016作成特別委員会:日本版敗血症診療ガイドライン2016. 日集中医誌 24(Suppl 2):S1-S232, 2016
 
4) Zarbock A, Schmidt C, Van Aken H et al:Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery:a randomized clinical trial. JAMA 313:2133-2141, 2015
PubMed
5) Zarbock A, Kellum JA, Van Aken H et al:Long-term effects of remote ischemic preconditioning on kidney function in high-risk cardiac surgery patients:follow-up results from the RenalRIP trial. Anesthesiology 126:787-798, 2017
PubMed
6) Hausenloy DJ, Candilio L, Evans R et al:Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med 373:1408-1417, 2015
PubMed
7) Meybohm P, Bein B, Brosteanu O et al:A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med 373:1397-1407, 2015
PubMed
8) Inoue T, Abe C, Sung SS et al:Vagus nerve stimulation mediates protection from kidney ischemia-reperfusion injury through α7nAChR+ splenocytes. J Clin Invest 126:1939-1952, 2016
 
9) Wilhelm-Leen E, Montez-Rath ME, Chertow G:Estimating the risk of radiocontrast-associated nephropathy. J Am Soc Naphrol 28:653-659, 2017
PubMed
10) Solomon R, Gordon P, Manoukian SV et al:Randomized trial of bicarbonate or saline study for the prevention of contrastinduced nephropathy in patients with CKD. Clin J Am Soc Nephrol 10:1519-1524, 2015
PubMed
11) Valette X, Desmeulles I, Savary B et al:Sodium bicarbonate versus sodium chloride for preventing contrast-associated acute kidney injury in critically ill patients:a randomized controlled trial. Crit Care Med 45:637-644, 2017
PubMed
12) Martin-Moreno PL, Varo N, Martinez-Anso E et al:Comparison of intravenous and oral hydration in the prevention of contrast-induced acute kidney injury in low-risk patients:a randomized trial. Nephron 131:51-58, 2015
PubMed
13) Bainey KR, Rahim S, Etherington K et al:Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization:results from the angiotensin converting enzyme inhibitor/angiotensin receptor blocker and contrast induced nephropathy in patients receiving cardiac catheterization (CAPTAIN) trial. Am Heart J 170:110-116, 2015
PubMed
14) Zarbock A, Kellum JA, Schmidt C et al:Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury:the ELAIN randomized clinical trial. JAMA 315:2190-2199, 2016
PubMed
15) Gaudry S, Hajage D, Schortgen F et al:Initiation strategies for renal- replacement therapy in the intensive care unit. N Engl J Med 375:122-133, 2016
PubMed
16) Koyner JL, Davison DL, Brasha-Mitchell E et al:Furosemide stress test and biomarkers for the prediction of AKI severity. J Am Soc Nephrol 26:2023-2031, 2015
PubMed
17) Ostermann M, Joannidis M, Pani A et al:Patient selection and timing of continuous renal replacement therapy. Blood Purif 42:224-237, 2016
PubMed
18) Thyregod HG, Steinbruchel DA, Ihlemann N et al:Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis:1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol 65:2184-2194, 2015
PubMed
19) Leon MB, Smith CR, Mack MJ et al:Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374:1609-1620, 2016
 
20) Reardon MJ, Van Mieghem NM, Popma JJ:Surgical or transcatheter aortic-valve replacement. N Engl J Med 377:197-198, 2017
 
21) Schauer PR, Bhatt DL, Kirwan JP et al:Bariatric surgery versus intensive medical therapy for diabetes-5-year outcomes. N Engl J Med 376:641-651, 2017
PubMed
22) Morgan DJ, Ho KM:Acute kidney injury in bariatric surgery patients requiring intensive care admission:a state-wide, multicenter, cohort study. Surg Obes Relat Dis 11:1300-1306, 2015
PubMed
23) Abdullah HR, Tan TP, Vaez M et al:Predictors of perioperative acute kidney injury in obese patients undergoing laparoscopic bariatric surgery:a singlecentre retrospective cohort study. Obes Surg 26:1493-1499, 2016
PubMed
24) Yunos NM, Bellomo R, Hegarty C et al:Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 308:1566-1572, 2012
PubMed
25) Young P, Bailey M, Beasley R et al:Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit:the SPLIT randomized clinical trial. JAMA 314:1701-1710, 2015
PubMed
26) Semler MW, Wanderer JP, Ehrenfeld JM et al:Balanced crystalloids versus saline in the intensive care unit:the SALT randomized trial. Am J Respir Crit Care Med 195:1362-1372, 2017
PubMed
27) Neyra JA, Canepa-Escaro F, Li X et al:Association of hyperchloremia with hospital mortality in critically ill septic patients. Crit Care Med 43:1938-1944, 2015
PubMed
28) Sadan O, Singbartl K, Kandiah PA et al:Hyperchloremia is associated withacute kidney injury in patients with subarachnoid hemorrhage. Crit Care Med 45:1382-1388, 2017
 
29) Toyonaga Y, Kikura M:Hyperchloremic acidosis is associated with acute kidney injury after abdominal surgery. Nephrology(Carlton) 22:720-727, 2017
PubMed
30) Legrand M, Le Cam B, Perbet S et al:Urine sodium concentration to predict fluid responsiveness in oliguric ICU patients:a prospective multicenter observational study. Crit Care 20:165, 2016
PubMed
31) Schmidt EP, Overdier KH, Sun X et al:Urinary glycosaminoglycans predict outcomes in septic shock and acute respiratory distress syndrome. Am J Respir Crit Care Med 194:439-449, 2016
PubMed
P.59 掲載の参考文献
1) Yatabe T, Inoue S, Sakaguchi M et al:The optimal target for acute glycemic control in critically ill patients:a network meta-analysis. Intensive Care Med 43:16-28, 2017
PubMed
2) Yamada T, Shojima N, Noma H et al:Glycemic control, mortality, and hypoglycemia in critically ill patients:a systematic review and network metaanalysis of randomized controlled trials. Intensive Care Med 43:1-15, 2017
 
3) Agus MS, Wypij D, Hirshberg EL et al:Tight glycemic control in critically ill children. N Engl J Med 376:729-741, 2017
PubMed
4) Rhodes A, Evans LE, Alhazzani W et al:Surviving Sepsis Campaign:international guidelines for management of sepsis and septic shock:2016. Crit Care Med 45:486-552, 2017
PubMed
5) Egi M, Krinsley JS, Maurer P et al:Premorbid glycemic control modifies the interaction between acute hypoglycemia and mortality. Intensive Care Med 42:562-571, 2016
PubMed
6) Marik PE, Egi M:Treatment thresholds for hyperglycemia in critically ill patients with and without diabetes. Intensive Care Med 40:1049-1051, 2014
PubMed
7) Kar P, Plummer MP, Bellomo R et al:Liberal glycemic control in critically ill patients with type2 diabetes:an exploratory study. Crit Care Med 44:1695-1703, 2016
 
8) Di Muzio F, Presello B, Glassford NJ et al:Liberal versus conventional glucose targets in critically ill diabetic patients:an exploratory safety cohort assessment. Crit Care Med 44:1683-1691, 2016
PubMed
9) Luethi N, Cioccari L, Crisman M et al:Prevalence of ketosis, ketonuria, and ketoacidosis during liberal glycemic control in critically ill patients with diabetes:an observational study. Crit Care 20:297, 2016
PubMed
10) Inoue S, Egi M, Kotani J et al:Accuracy of blood-glucose measurements using glucose meters and arterial blood gas analyzers in critically ill adult patients:systematic review. Crit Care 17:R48, 2013
PubMed
11) Liang Y, Wanderer J, Nichols JH et al:Blood gas analyzer accuracy of glucose measurements. Mayo Clin Proc 92:1030-1041, 2017
PubMed
12) Krinsley JS, Chase JG, Gunst J et al:Continuous glucose monitoring in the ICU:clinical considerations and consensus. Crit Care 21:197, 2017
PubMed
13) Sato H, Hosojima M, Ishikawa T et al:Glucose variability based on continuous glucose monitoring assessment is associated with postoperative complications after cardiovascular surgery. Ann Thorac Cardiovasc Surg 23:239-247, 2017
PubMed
14) Preechasuk L, Suwansaksri N, Ipichart N et al:Hyperglycemia and glycemic variability are associated with the severity of sepsis in nondiabetic subjects. J Crit Care 38:319-323, 2017
PubMed
15) Ancona P, Eastwood GM, Lucchetta L et al:The performance of flash glucose monitoring in critically ill patients with diabetes. Crit Care Resusc 19:167-174, 2017
 
16) De Block CE, Gios J, Verheyen N et al:Randomized evaluation of glycemic control in the medical intensive care unit using real-time continuous glucose monitoring(REGIMEN Trial). Diabetes Technol Ther 17:889-898, 2015
PubMed
17) Carpenter DL, Gregg SR, Xu K et al:Prevalence and impact of unknown diabetes in the ICU. Crit Care Med 43:e541-550, 2015
PubMed
18) Luethi N, Cioccari L, Tanaka A et al:Glycated hemoglobin A1c levels are not affected by critical illness. Crit Care Med 44:1692-1694, 2016
 
19) Van Ackerbroeck S, Schepens T, Janssens K et al:Incidence and predisposing factors for the development of disturbed glucose metabolism and DIabetes mellitus AFter Intensive Care admission:the DIAFIC study. Crit Care 19:355, 2015
 
20) Ali Abdelhamid Y, Kar P, Finnis ME et al:Stress hyperglycaemia in critically ill patients and the subsequent risk of diabetes:a systematic review and metaanalysis. Crit Care 20:301, 2016
PubMed
21) Jivanji CJ, Asrani VM, Windsor JA et al:New-onset diabetes after acute and critical illness:a systematic review. Mayo Clin Proc 92:762-773, 2017
PubMed
22) Keh D, Trips E, Marx G et al:Effect of hydrocortisone on development of shock among patients with severe sepsis:the HYPRESS randomized clinical trial. JAMA 316:1775-1785, 2016
PubMed
23) Billot L, Venkatesh B, Myburgh J et al:Statistical analysis plan for the Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock(ADRENAL) trial. Crit Care Resusc 19:183-191, 2017
 
24) Egi M, Morita K:Fever in non-neurological critically ill patients:A systematic review of observational studies. J Crit Care 27:428-433, 2012
PubMed
25) Young P, Saxena M, Bellomo R et al:Acetaminophen for fever in critically ill patients with suspected infection. N Engl J Med 373:2215-2224, 2015
PubMed
26) Schell-Chaple HM, Liu KD, Matthay MA et al:Effects of IV acetaminophen on core body temperature and hemodynamic responses in febrile critically ill adults:a randomized controlled trial. Crit Care Med 45:1199-1207, 2017
PubMed
27) Cantais A, Schnell D, Vincent F et al:Acetaminophen-induced changes in systemic blood pressure in critically ill patients:results of a multicenter cohort study. Crit Care Med 44:2192-2198, 2016
PubMed
28) Drewry AM, Ablordeppey EA, Murray ET et al:Antipyretic therapy in critically ill septic patients:a systematic review and meta-analysis. Crit Care Med 45:806-813, 2017
PubMed
P.66 掲載の参考文献
1) Rhodes A, Evans LE, Alhazzani W et al:Surviving Sepsis Campaign:international guidelines for management of sepsis and septic shock:2016. Intensive Care Med 43:304-377, 2017
PubMed
2) 日本集中治療医学会・日本救急医学会合同日本版敗血症診療ガイドライン2016作成特別委員会:日本版敗血症診療ガイドライン2016. 日集中医誌 24(suppl 2):S1-232, 2017
 
3) Umemura Y, Yamakawa K, Ogura H et al:Efficacy and safety of anticoagulant therapy in three specific populations with sepsis:a meta-analysis of randomized controlled trials. J Thromb Haemost 14:518-530, 2016
PubMed
4) Yamakawa K, Umemura Y, Hayakawa M et al:Benefit profile of anticoagulant therapy in sepsis:a nationwide multicentre registry in Japan. Crit Care 20:229, 2016
PubMed
5) Gando S, Meziani F, Levi M:What's new in the diagnostic criteria of disseminated intravascular coagulation? Intensive Care Med 42:1062-1064, 2016
 
6) Allingstrup M, Wetterslev J, Ravn FB et al:Antithrombin III for critically ill patients:a systematic review with metaanalysis and trial sequential analysis. Intensive Care Med 42:505-520, 2016
PubMed
7) Iba T, Thachil J:Is antithrombin III for sepsis-associated disseminated intravascular coagulation really ineffective? ntensive Care Med 42:1193-1194, 2016
 
8) Iba T, Gando S, Saitoh D et al:Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation. Thromb Res 145:46-50, 2016
PubMed
9) Yamakawa K, Aihara M, Ogura H et al:Recombinant human soluble thrombomodulin in severe sepsis:a systematic review and meta-analysis. J Thromb Haemost 13:508-519, 2015
PubMed
10) Hagiwara A, Tanaka N, Uemura T et al:Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation:a single-centre, open-label, randomised controlled trial. BMJ open 6:e012850, 2016
PubMed
11) Hayakawa M, Yamakawa K, Saito S et al:Recombinant human soluble thrombomodulin and mortality in sepsisinduced disseminated intravascular coagulation:a multicentre retrospective study. Thromb Haemost 115:1157-1166, 2016
PubMed
12) Iba T, Gando S, Saitoh D et al:Efficacy and bleeding risk of antithrombin supplementation in patients with septic disseminated intravascular coagulation:a third survey. Clin Appl Thromb Hemost 23:422-428, 2017
PubMed
13) Davenport RA, Guerreiro M, Frith D et al:Activated protein c drives the hyperfibrinolysis of acute traumatic coagulopathy. Anesthesiology 126:115-127, 2017
PubMed
14) Rossaint R, Bouillon B, Cerny V et al:The European guideline on management of major bleeding and coagulopathy following trauma:fourth edition. Crit Care20:100, 2016
 
15) Nishida T, Kinoshita T, Yamakawa K:Tranexamic acid and trauma-induced coagulopathy. Journal of intensive care 5:5, 2017
PubMed
16) Moore HB, Moore EE, Huebner BR et al:Tranexamic acid is associated with increased mortality in patients with physiological fibrinolysis. J Surg Res, 2017 May 8[Epub ahead of print]
 
17) Abdelfattah K, Cripps MW:Thromboelastography and rotational thromboelastometry use in trauma. Int J Surg 33(Pt B):196-201, 2016
 
18) Hunt H, Stanworth S, Curry N et al:Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding. Cochrane Database Syst Rev 16:CD010438, 2015
 
19) Levi M, Hunt BJ:A critical appraisal of point-of-care coagulation testing in critically ill patients. J Thromb Haemost 13:1960-1967, 2015
PubMed
20) David JS, Bouzat P:Early fibrinogenconcentrate administration in management of trauma-induced coagulopathy. Lancet Haematol 4:e348 2017
PubMed
21) Innerhofer P, Fries D, Mittermayr M et al:Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma(RETIC):a single-centre, parallel-group, open-label, randomised trial. Lancet Haematol 4:e258-e271, 2017
 
22) Yamamoto K, Yamaguchi A, Sawano M et al:Pre-emptive administration of fibrinogen concentrate contributes to improved prognosis in patients with severe trauma. Trauma Surg Acute Care Open 1:1-5, 2016
PubMed
23) Steinmetz J, Sorensen AM, Henriksen HH et al:Pilot randomized trial of fibrinogen in trauma haemorrhage (PRooF-iTH):study protocol for a randomized controlled trial. Trials 17:327, 2016
PubMed
24) Hayakawa M, Maekawa K, Kushimoto S et al:Hyperfibrinolysis in severe isolated traumatic brain injury may occur without tissue hypoperfusion:a retrospective observational multicentre study. Crit Care 21:222, 2017
PubMed
25) Wada T, Gando S, Maekaw K et al:Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury. Crit Care 21:219, 2017
PubMed
26) Mahmood A, Roberts I, Shakur H:A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic braininjury:study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS]). Trials 18:330, 2017
 
27) Pollack CV Jr., Reilly PA, van Ryn J et al:Idarucizumab for dabigatran reversal:full cohort analysis. N Engl J Med 377:431-441, 2017
PubMed
28) Connolly SJ, Milling TJ Jr., Eikelboom JW et al:Andexanet alfa for acutemajor bleeding associated with factor Xa inhibitors. N Engl J Med 375:1131-1141, 2016
PubMed
29) Ansell JE, Bakhru SH, Laulicht BE et al:Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban. Thromb Haemost 117:238-245, 2017
PubMed
P.73 掲載の参考文献
1) Carson JL, Guyatt G, Heddle NM et al:Clinical practice guidelines from the AABB:red blood cell transfusion thresholds and storage. JAMA 316:2025-2035, 2016
PubMed
2) Aung HH, Tung JP, Dean MM et al:Procoagulant role of microparticles in routine storage of packed red blood cells:potential risk for prothrombotic posttransfusion complications. Pathology 49:62-69, 2017
PubMed
3) Sut C, Tariket S, Chou ML et al:Duration of red blood cell storage and inflammatory marker generation. Blood Transfus 15:145-152, 2017
PubMed
4) Rapido F, Brittenham GM, Bandyopadhyay S et al:Prolonged red cell storage before transfusion increases extravascular hemolysis. J Clin Invest. 127:375-382, 2017
PubMed
5) Bennet-Guerrero E, Lockhart EL, Bandarenko N et al:A randomized controlled pilot study of VO2 max testing:a potential model for measuring relative in vivo efficacy of different red blood cell products. Transfusion 57:630-636, 2017
 
6) Kim E, Kim HC, Park SY et al:Effect of red blood cell transfusion on unfavorable neurologic outcome and symptomatic vasospasm in patients with cerebralaneurysmal rupture:old versus fresh blood. World Neurosurg 84:1877-1886, 2015
 
7) Steiner ME, Ness PM, Assmann SF et al:Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med 372:1419-1429, 2015
PubMed
8) Heddle NM, Cook RJ, Arnold DM et al:Effect of short-term vs. long-term blood storage on mortality after transfusion. N Engl J Med 375:1937-1945, 2016
PubMed
9) Cooper DJ, McQuilten ZK, Nichol A et al:Age of red cells for transfusion and outcomes in critically ill adults. N Engl J Med 377:1858-1867, 2017
PubMed
10) Dhabangi A, Ainomugisha B, Cserti-Gazedewich C at al:Effect of transfusion of red blood cells with longer vs shorter storage duration on elevated blood lactate levels in children with severe anemia, the TOTAL randomized clinical trial. JAMA 314:2514-2523, 2015
 
11) Zhang ZY, Gao DP, Yang JJ et al:Impact of length of red blood cells transfusion on postoperative delirium in elderly patients undergoing hip fracture surgery:a cohort study. Injury 47:408-412, 2016
PubMed
12) Van der Zanden V, Beishuizen SJ, Scholtens RM et al:The effects of blood transfusion on delirium incidence. J Am Med Dir Assoc 17:748-753, 2016
PubMed
13) Van der Zanden V, Beishuizen SJ, Swart LM et al:The effect of treatment of anemia with blood transfusion on delirium:a systematic review. J Am Geriatr Soc 65:728-737, 2017
PubMed
14) Oh CS, Park S, Hong SW et al:Postoperative delirium in patients undergoing off-pump coronary artery bypass grafting according to the anesthetic agent:a retrospective study. Journal of Cardiothoracic and Vascular Anesthesia. 2017 in press
 
15) Gosselt AN, Slooter AJ, Boere PR et al:Risk factors for delirium after on-pump cardiac surgery:a systematic review. Crit Care 19:346, 2015
 
16) Rudiger A, Begdeda H, Babic D et al:Intra-operative events during cardiac surgery are risk factors for the development of delirium in the ICU. Crit Care 20:264, 2016
PubMed
17) Van der Sluis FJ, Buisman PL, Meerdink M et al:Risk factors for postoperative delirium after colorectal operation. Surgery 161:704-11, 2017
PubMed
18) Hasegawa T, Saito I, Takeda D et al:Risk factors associated with postoperative delirium after surgery for oral cancer. J Craniomaxillofac Surg 43:1094-1098, 2015
PubMed
19) 西田 修, 小倉裕司, 井上茂亮 他:日本版敗血症診療ガイドライン2016(J-SSCG2016). 日救急医会誌. 28:S1-S232, 2017
 
20) Rhodes A, Evans LE, Alhazzani W et al:Surviving Sepsis Campaign:International guidelines for management of sepsis and septic shock:2016. Crit Care Med 45:486-552, 2017
PubMed
21) Wand S, Klages M, Kirbach C et al:IgM-enriched immunoglobulin attenuates systemic endotoxin activity in early severe sepsis:a before-after cohort study. PLoS One 11:e0160907, 2016
PubMed
22) Sallam MM, Abou-Aisha K, El-AziziM:A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria. Infec Drug Resist 9:301-311, 2016
 
23) Shimizu M, Katoh H, Hamaoka S et al:Protective effects of intravenous immunoglobulin and antimicrobial agents on acute pneumonia in leukopenic mice. J Infect Chemother 22:240-247, 2016
PubMed
24) Loubaki L, Chabot D, Pare I et al:MiR-146a potentially promotes IVIg-mediated inhibition of TLR4 signaling in LPSactivated human monocytes. Immunol Lett 185:64-73, 2017
PubMed
P.78 掲載の参考文献
1) Noto MJ, Domenico HJ, Byrne DW et al:Chlorhexidine bathing and health careassociated infections:a randomized clinical trial. JAMA 313:369-378, 2015
PubMed
2) Kim HY, Lee WK, Na S et al:The effects of chlorhexidine gluconate bathing on health care-associated infection in intensive care units:a meta-analysis. J Crit Care 32:126-137, 2016
PubMed
3) O'Grady NP, Alexander M, Burns LA et al;Healthcare Infection Control Practices Advisory Committee:Guidelines for the prevention of intravascular catheterrelated infections. Am J Infect Control 39:S1-34, 2011
PubMed
4) Chaiyakunapruk N, Veenstra DL, Lipsky BA et al:Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care:a meta-analysis. Ann Intern Med 136:792-801, 2002
 
5) Mimoz O, Lucet JC, Kerforne T et al;CLEAN trial investigators:Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection(CLEAN):an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 386:2069-2077, 2015
 
6) Arvaniti K, Lathyris D, Blot S et al:Cumulative evidence of randomized controlled and observational studies on catheter-related infection risk of central venous catheter insertion site in ICU patients:a pairwise and network metaanalysis. Crit Care Med 45:e437-e448, 2017
PubMed
7) Parienti JJ, Mongardon N, Megarbane B et al;3SITES Study Group:Intravascular complications of central venous catheterization by insertion site. N Engl J Med 373:1220-1229, 2015
 
8) Hoeboer SH, van der Geest PJ, Nieboer D et al:The diagnostic accuracy of procalcitonin for bacteraemia:a systematic review and meta-analysis. Clin Microbiol Infect 21:474-481, 2015
PubMed
9) Liu D, Su L, Han G et al:Prognostic value of procalcitonin in adult patients with sepsis:a systematic review and netaanalysis. PLoS ONE 10:e0129450, 2015
PubMed
10) Bouadma L, Luyt CE, Tubach F et al;PRORATA trial group:Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units(PRORATA trial):a multicentre randomised controlled trial. Lancet 375:463-474, 2010
 
11) Zhang T, Wang Y, Yang Q et al:Procalcitonin-guided antibiotic therapy incritically ill adults:a meta-analysis. BMC Infect Dis 17:514, 2017
 
12) Wu CC, Lan HM, Han ST et al:Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein:a systematic review and meta-analysis. Ann Intensive Care 7:91, 2017
 
13) Masson S, Caironi P, Fanizza C et al:Circulating presepsin(soluble CD14 subtype)as a marker of host response in patients with severe sepsis or septic shock:data from the multicenter, randomized ALBIOS trial. Intensive Care Med 41:12-20, 2015
 
P.82 掲載の参考文献
1) Harvey SE, Parrott F, Harrison DA et al:Trial of the route of aarly nutritional support in critically ill adults. N Engl J Med 371:1673-1684, 2014
PubMed
2) Elke G, van Zanten AR, Lemieux M et al:Enteral versus parenteral nutrition in critically ill patients:an updated systematic review and meta-analysis of randomized controlled trials. Crit Care 20:117, 2016
PubMed
3) Harvey SE, Parrott F, Harrison DA et al:A multicentre, randomised controlled trial comparing the clinical effectiveness and cost-effectiveness of early nutritional support via the parenteral versus the enteral route in critically ill patients(CALORIES).Health Technol Assess 20:1-144, 2016
PubMed
4) van Barneveld KW, Smeets BJ, Heesakkers FF et al:Beneficial effects of early enteral nutrition after major rectal surgery:a possible role for conditionally essential amino acids? results of a randomized clinical trial. Crit Care Med 44:e353-361, 2016
PubMed
5) Reignier J, Darmon M, Sonneville R et al:Impact of early nutrition and feeding route on outcomes of mechanically ventilated patients with shock:a post hoc marginal structural model study. Intensive Care Med 41:875-886, 2015
 
6) Khalid I, Doshi P, DiGiovine B:Early enteral nutrition and outcomes of critically ill patients treated with vasopressors and mechanical ventilation. Am J Crit Care 19:261-268, 2010
 
7) Prakash V, Parameswaran N, Biswal N et al:Early versus late enteral feeding in critically ill children:a randomized controlled trial. Intensive Care Med 42:481-482, 2016
PubMed
8) Reintam Blaser A, Starkopd J, Alhazzani W et al:Early ente/ral nutrition in critically ill patients:ESICM clinical practice guidelines. Intensive Care Med 43:380-398, 2017
 
9) Koretz RL, Lipman TO:The presence and effect of bias in trials of early enteral nutrition in critical care. Clinical Nutrition 33:240-245, 2014
PubMed
10) 日本版敗血症診療ガイドライン2016作成特別委員会:日本版敗血症診療ガイドライン2016. 日救急医会誌 28:S1-S4, 2017
 
11) 小谷穣治, 江木盛時, 亀井有子 他:日本版重症患者の栄養療法ガイドライン. 日集中医誌 23:185-281, 2016
 
12) Berger MM, Soguel L, Charriere M et al:Impact of the reduction of the recommended energy target in the ICU on protein delivery and clinical outcomes. Clinical Nutrition 36:281-287, 2017
PubMed
13) Petros S, Horbach M, Seidel F:Hypocaloric vs normocaloric nutrition in critically ill patients:a prospective randomized pilot trial. JPEN J Parenter Enteral Nutr 40:242-249, 2016
PubMed
14) Arabi YM, Aldawood AS, Haddad SH et al:Permissive underfeeding or standard enteral feeding in critically ill adults. N Engl J Med 372:2398-2408, 2015
 
15) Arabi YM, Aldawood AS, Al-Dorzi HM, et al:Permissive underfeeding or standard enteral feeding in high- and low-nutritional-risk critically ill adults post hoc analysis of the PermiT trial. American Journal of Respiratory and Critical Care Medicine 195:652-662, 2017
 
16) Doig GS, Simpson F, Heighes PT et al:Restricted versus continued standard caloric intake during the management of refeeding syndrome in critically ill adults:a randomised, parallel-group, multicentre, single-blind controlled trial. Lancet Respir Med 3:943-952, 2015
PubMed
17) Braunschweig CA, Sheean PM, Peterson SJ et al:Intensive nutrition in acute lung injury:a clinical trial (INTACT). JPEN J Parenter Enteral Nutr 39:13-20, 2015
PubMed
18) Peterson SJ, Lateef OB, Freels S et al:Early exposure to recommended calorie delivery in the intensive care unit is associated with increased mortality in patients with acute respiratory distress syndrome. JPEN J Parenter Enteral Nutr, 2017 Jun 1[Epub ahead of print]
 
19) Braunschweig CL, Freels S, Sheean PM et al:Role of timing and dose of energy received in patients with acute lung injury on mortality in the Intensive Nutrition in Acute Lung Injury Trial (INTACT):a post hoc analysis. Am J Clin Nutr 105:411-416, 2017
PubMed
20) Heyland DK, Dhaliwal R, Day AG et al;Canadian Critical Care Trials Group:REducing Deaths due to OXidative Stress (The REDOXS Study):rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc 65:250-263, 2006
PubMed
21) Wei X, Day AG, Ouellette-Kuntz H et al:The association between nutritional adequacy and long-term outcomes in critically ill patients requiring prolonged mechanical ventilation:a multicenter cohort study. Crit Care Med 43:1569-1579, 2015
PubMed
22) Owaisa AE, Kabira SI, Mcnaughta C et al:A single-blinded randomised clinical trial of permissive underfeeding in patients requiring parenteral nutrition. Clinical Nutrition 33:997-1001, 2014
 
23) Heyland DK et al. https://www.criticalcarenutrition.com/docs/cpgs2012/10.1.pdf
 
24) Heyland DK, Cahill N, Day AG:Optimal amount of calories for critically ill patients:Depends on how you slice the cake! Crit Care Med 39:2619-2626, 2011
PubMed
25) Zusman O, Theilla M, Cohen J:Resting energy expenditure, calorie and protein consumption in critically ill patients:a retrospective cohort study. Crit Care 20:367, 2016
PubMed
26) Compher C, Chittams J, Sammarco T et al:Greater protein and energy intake may be associated with improved mortality in higher risk critically ill patients:a multicenter, multinational observational study. Crit Care Med 45:156-163, 2017
PubMed
27) Fivez T, Kerklaan D, Mesotten D et al:Early versus late parenteral nutrition in critically ill children. N Engl J Med 374:1111-1122, 2016
PubMed
28) Vanhorebeek I, Verbruggen S, Casaer MP et al:Effect of early supplemental parenteral nutrition in the paediatric ICU:a preplanned observational study of post-randomisation treatments in the PEPaNIC trial. Lancet Respir Med 5:475-483, 2017
PubMed
29) Casaer MP, Mesotten D, Hermans G et al:Early versus late parenteral nutrition in critically ill adults. N Engl J Med 365:506-517, 2011
PubMed
30) Hermans G, Casaer MP, Clerckx B:Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness:a subanalysis of the EPaNIC trial. Lancet Respir Med 1:621-629, 2013
PubMed
31) Casaer MP, Wilmer A, Hermans G et al:Role of disease and macronutrient dose in the randomized controlled EPaNIC trial:a post hoc analysis. Am J Respir Crit Care Med 187:247-255, 2013
 
32) Wischmeyer PE, Hasselmann M, Kummerlen C et al:A randomized trial of supplemental parenteral nutrition in underweight and overweight critically ill patients:the TOP-UP pilot trial. Critical Care 21:142, 2017
 
33) Rugeles SJ, Rueda JD, Diaz CE et al:Hyperproteic hypocaloric enteral nutrition in the critically ill patient:a randomized controlled clinical trial. Indian J Crit Care Med 17:343-349, 2013
 
34) Ferrie S, Allman-Farinelli M, Daley M et al:Protein requirements in the critically ill:a randomized controlled Trial Using Parenteral Nutrition. JPEN J Parenter Enteral Nutr 40:795-805, 2016
PubMed
35) Nicolo M, Heyland DK, Chittams J et al:Clinical outcomes related to protein delivery in a critically ill population:a multicenter, multinational observation study. JPEN J Parenter Enteral Nutr 40:45-51, 2016
 
36) Weijs PJ, Looijaard WG, Beishuizen A et al: Early high protein intake isassociated with low mortality and energy overfeeding with highmortality in nonseptic mechanically ventilated critically ill patients. Crit Care 18:701, 2014
 
37) Paule Wischmeyer Nutrition Therapyin Sepsis. Critical Care Clinics Available online, 2017
 
38) Hurt RT, McClave SA, Martindale RG et al:Summary points and consensus recommendations from the international protein summit. Nutr Clin Pract 32:142S-151S, 2017
PubMed
39) Stephen AM, Mohamed AS, Mark E et al:Volume-based feeding in the critically ill patient. Journal of Parenteral and EnteralNutrition 39:707-712, 2015
 
40) Hurt RT, McClave SA, Evans DC et al:Targeted physician education positively affects delivery of nutrition therapy and patient outcomes:results of a prospective clinical trial. JPEN J Parenter Enteral Nutr 39:948-952, 2015
PubMed
41) Ziegler TR, May AK, Hebbar G et al:Efficacy and safety of glutaminesupplemented parenteral nutrition in surgical ICU patients:an American multicenter randomized controlled trial.Ann Surg 263:646-655, 2016
PubMed
42) Jordan I, Balaguer M, Esteban ME et al:Glutamine effects on heat shock protein 70 and interleukines 6 and 10:randomized trial of glutamine supplementation versus standard parenteral nutrition in critically ill children. Clin Nutr 35:34-40, 2016
PubMed
43) Grintescu IM, Luca Vasiliu I, Cucereanu Badica I et al:The influence of parenteral glutamine supplementation on glucose homeostasis in critically ill polytrauma patients:a randomized-controlled clinical study. Clin Nutr 34:377-382, 2015
PubMed
44) Heyland DK, Elke G, Cook D et al:Glutamine and antioxidants in the critically ill patient:a post hoc analysis of a large-scale randomized trial. JPEN J Parenter Enteral Nutr 39:401-409, 2015
 
45) Allingstrup MJ, Kondrup J, Wiis J et al:Early goal-directed nutrition versus standard of care in adult intensive care patients:the single-centre, randomised, outcome assessor-blinded EAT-ICU trial. Intensive Care Med. 43:1637-1647, 2017
 
46) Reignier J, Boisrame-Helms J, Brisard L et al:Enteral versus parenteral early nutrition in ventilated adults with shock:a randomised, controlled, multicentre, openlabel, parallel-group study(NUTRIREA-2). Lancet, 2017 Nov 8[Epub ahead of print]
 
47) Merchan C, Altshuler D, Aberle C et al:Tolerability of enteral nutrition in mechanically ventilated patients with septic shock who require vasopressors. J Intensive Care Med 32:540-546, 2017
PubMed
P.91 掲載の参考文献
1) Gupta P, Rettiganti M, Gossett JM et al:Risk factors for mechanical ventilation and reintubation after pediatric heart surgery. J Thorac Cardiovasc Surg 151:451-458, 2016
PubMed
2) Gaies M, Tabbutt S, Schwartz SM et al:Clinical epidemiology of extubation failure in the pediatric cardiac ICU:a report from the pediatric cardiac critical care consortium. Pediatr Crit Care Med 16:837-845, 2015
PubMed
3) Diaz F, Benfield M, Brown L et al:Fluid overload and outcomes in critically ill children:a single center prospective cohort study. J of Crit Care 39:209-213, 2017
PubMed
4) Rhodes A, Evans LE, Alhazzani W et al:Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock:2016. Crit Care Med 45:486-552, 2017
PubMed
5) Weiss SL, Fitzgerald JC, Pappachan J et al:Global epidemioogy of pediatric severe sepsis:the sepsis prevalence, outcome, and therapies study. Am J Respir Crit Care Med 191:1147-1157, 2015
 
6) Ramaswamy KN, Singhi S, Jayashree M et al:Double-blind randomized clinical trial comparing dopamine and epinephrine in pediatric fluid-refractory hypotensive septic shock. Pediatr Crit Care Med 17:e502-e512, 2016
PubMed
7) Ranieri VM, Rubenfeld GD, Thompson BT et al:Acute respiratory distress syndrome:the Berlin definition. JAMA 307:2526-2533, 2012
PubMed
8) Khemani RG, Smith LS, Zimmerman JJ et al:Pediatric acute respiratory distress syndrome:definition, incidence, and epidemiology:proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med 16:S23-S40, 2015
PubMed
9) Yehya N, Servaes S, Thomas NJ:Characterizing degree of lung injury in pediatric acute respiratory distress syndrome. Crit Care Med 43:937-946, 2015
PubMed
10) Bateman ST, Borasino S, Asaro LA et al:Early high-frequency oscillatory ventilation in pediatric acute respiratory failure. a propensity score analysis. Am J Respir Crit Care Med 193:495-503, 2016
PubMed
11) Gupta P, Richardson T, Hall M et al:Effect of inhaled nitric oxide on outcomes in children with acute lung injury:propensity matched analysis from a linked database. Crit Care Med 44:1901-1909, 2016
PubMed
12) Crompton EM, Lubomirova I, Cotlarciuc I et al:Meta-analysis of therapeutic hypothermia for traumatic brain injury in adult and pediatric patients. Crit Care Med 45:575-583, 2017
PubMed
13) Andrews PJ, Sinclair HL, Rodriguez A et al:Hypothermia for intracranial hypertension after traumatic brain injury. N Engl J Med 373:2403-2412, 2015
PubMed
14) Moler FW, Silverstein FS, Holubkov R et al:Therapeutic hypothermia after inhospital cardiac arrest in children. N Engl J Med 376:318-329, 2017
PubMed
15) Moler FW, Silverstein FS, Holubkov R et al:Therapeutic hypothermia after out-ofhospital cardiac arrest in children, N Engl J Med 372:1898-1908, 2015
 
16) Kaddourah A, Basu RK, Bagshaw SM et al:Epidemiology of acute kidney injury in crically ill children and young adults. N Engl J Med 376:11-20, 2017
 
17) Pinto NP, Rhinesmith EW, Kim TY et al:Long-term function after pediatric crial illness:results from the survivor outcomes study. Pediatr Crit Care Med 18:e122-e130, 2017
PubMed
18) Pollack MM, Holubkov R, Glass P et al:Functional Status Scale: new pediatric outcome measure. Pediatr 124:e18-e28, 2009
 
19) van Zellem L, Buysse C, Madderom M et al:Long-term neuropsychological outcomes in children and adolescents after cardiac arrest. Intensive Care Med 41:1057-1066, 2015
PubMed
20) Meert KL, Keele L, Morrison W et al:End-of-life practices among tertiary care PICUs in the United States:a multicenter study. Pediatr Crit Care Med 16:e231-e238, 2015
PubMed

II章 集中治療における検査・技術

P.98 掲載の参考文献
1) Parnia S, Yang J, Nguyen R et al:Cerebral oximetry during cardiac arrest: a multicenter study of neurologic outcomes and survival. Crit Care Med 44:1663-1674, 2016
PubMed
2) Khawaja AM, Wang G, Cuter GR et al:Continuous electroencephalography(cEEG)monitoring and outcomes of critically ill patients. Med Sci Monit 23:649-658, 2017
 
3) Faritous Z, Barzanji A, Azarfarin R et al:Comparison of Bispectral Index Monitoring with the Critical-Care Pain Observation Tool in the pain assessment of intubated adult patients after cardiac surgery. Anesth Pain Med 6:e38334, 2016
PubMed
4) 山田章子, 池松裕子:日本語版Critical-Care Pain Observation Tool(CPOT-J)の信頼性・妥当性・反応性の検証. 日集中医誌 23:133-140, 2016
 
5) Vincent JL, Quintairos E Silva A, Couto L Jr et al:The value of blood lactate kinetics in critically ill patients:a systematic review. Crit Care 20:257, 2016
PubMed
6) Bochicchio GV, Nasraway S, Moore L et al:Results of a multicenter prospective pivotal trial of the first inline continuous glucose monitor in critically ill patients. J Trauma Acute Care Surg 82:1049-1054, 2017
PubMed
7) Mayer K, Trzeciak S, Puri NK et al:Assessment of the adequacy of oxygen delivery. Curr Opin Crit Care 22:437-443, 2016
PubMed
8) Hasanin A, Mukhtar A, Nassar H:Perfusion indices revisited. J Intensive Care 5:24, 2017
PubMed
9) Naumann DN, Mellis C, Husheer SL et al:Real-time point of care microcirculatory assessment of shock:design, rationale and application of the point of care microcirculation (POEM) tool. Crit Care 20:310, 2016
PubMed
10) Schwarz SB, Windisch W, Magnet FS:Continuous non-invasive PCO2 monitoring in weaning patients:Transcutaneous is advantageous over end-tidal PCO2. Respirology 8:1579-1584, 2017
PubMed
11) Szmuk P, Steiner JW, Olomu PN et al:Oxygen Reserve Index:a novel noninvasive measure of oxygen reserve:a pilot study. Anesthesiology 124:779-784, 2016
PubMed
12) Grieco DL, Chen L, Brochard L:Transpulmonary pressure:importance and limits. Ann Transl Med 5:285, 2017
PubMed
13) Vincent JL, Taccone FS, He X:Harmful effects of hyperoxia in postcardiac arrest, sepsis, traumatic brain injury, or stroke:the importance of individualized oxygen therapy in critically ill patients. Can Respir J 2017:2834956, 2017
PubMed
14) Alzahrani SA, Al-Salamah MA, Al-Madani WH et al:Systematic review and metaanalysis for the use of ultrasound versus radiology in diagnosing of pneumonia. Crit Ultrasound J 9:6, 2017
 
15) Honore PM, Spapen HD:Passive leg raising test with minimally invasive monitoring:the way forward for guiding septic shock resuscitation? J Intensive Care 5:36, 2017
PubMed
16) Monnet X, Marik P, Teboul JL:Passive leg raising for predicting fluid responsiveness:a systematic review and meta-analysis. Intensive Care Med 42:1935-1947, 2016
PubMed
17) Li DK, Wang XT, Liu DW:Association between elevated central venous pressure and outcomes in critically ill patients. Ann Intensive Care 7:83, 2017
PubMed
18) Teboul JL, Saugel B, Cecconi M et al:Less invasive hemodynamic monitoring in critically ill patients. Intensive Care Med 42:1350-1359, 2016
PubMed
19) Michard F, Pinsky MR, Vincent JL:Intensive care medicine in 2050:NEWS for hemodynamic monitoring. Intensive Care Med 43:440-442, 2017
PubMed
20) Harvey JB, Yeager BE, Cramer C et al:The impact of telemedicine on pediatric critical care triage. Pediatr Crit Care Med, 2017 Sep 15[Epub ahead of print]
 
P.103 掲載の参考文献
1) O'Grady NP, Alexander M, Burns LA et al:Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52:e162-193, 2011
PubMed
2) Maki DG, Ringer M, Alvarado CJ:Prospective randomised trial of povidoneiodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 338:339-343, 1991
PubMed
3) Humar A, Ostromecki A, Direnfeld J et al:Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis 31:1001-1007, 2000
PubMed
4) Valles J, Fernandez I, Alcaraz D et al:Prospective randomized trial of 3 antiseptic solutions for prevention of catheter colonization in an intensive care unit for adult patients. Infect Control Hosp Epidemiol 29:847-853, 2008
 
5) Yamamoto N, Kimura H, Misao H et al:Efficacy of 1.0% chlorhexidinegluconate ethanol compared with 10% povidone-iodine for long-term central venous catheter care in hematology departments:a prospective study. Am J Infect Control 42:574-576, 2014
 
6) Chaiyakunapruk N, Veenstra DL, Lipsky BA et al:Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care:a meta-analysis. Ann Intern Med 136:792-801, 2002
 
7) Lai NM, Lai NA, O'Riordan E et al:Skin antisepsis for reducing central venous catheter-related infections. Cochrane Database Syst Rev 7:CD010140, 2016
PubMed
8) Mimoz O, Lucet JC, Kerforne T et al:Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection(CLEAN):an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 386:2069-2077, 2015
PubMed
9) Cohen DM, Carino GP, Heffernan DS et al:Arterial catheter use in the ICU:a national survey of antiseptic technique and perceived infectious risk. Crit Care Med 43:2346-2353, 2015
PubMed
10) 厚生労働省院内感染対策サーベイランス事業(JANIS)ICU部門部門. https://janis.mhlw.go.jp/report/open_report/2016/3/3/ICU_Open_Report_201600.pdf
 
11) Hsu DJ, Feng M, Kothari R et al:The association between indwelling arterial catheters and mortality in hemodynamically stable patients with respiratory failure:a propensity score analysis. Chest 148:1470-1476, 2015
PubMed
12) Pawson SR, DePriest JL:Are blood gases necessary in mechanically ventilated patients who have successfully completed a spontaneous breathing trial? Respir Care 49:1316-1319, 2004
PubMed
13) Nolan ME, Yadav H, Cawcutt KA et al:Complication rates among peripherally inserted central venous catheters and centrally inserted central catheters in the medical intensive care unit. J Crit Care 31:238-242, 2016
PubMed
14) Ricard JD, Salomon L, Boyer A et al:Central or peripheral catheters for initial venous access of ICU patients:a randomized controlled trial. Crit Care Med 41:2108-2115, 2013
 
15) Helm RE, Klausner JD, Klemperer JD et al:Accepted but unacceptable:peripheral IV catheter failure. J Infus Nurs 38:189-203, 2015
PubMed
16) Murayama R, Uchida M, Oe M et al:Removal of peripheral intravenous catheters due to catheter failures among adult patients. J Infus Nurs 40:224-231, 2017
PubMed
17) Gunther SC, Schwebel C, Hamidfar-Roy R et al:Complications of intravascular catheters in ICU:definitions, incidence and severity. a randomized controlled trial comparing usual transparent dressings versus new-generation dressings(the ADVANCED study). Intensive Care Med 42:1753-1765, 2016
PubMed
18) Maki DG, Kluger DM, Crnich CJ:The risk of bloodstream infection in adults with different intravascular devices:a systematic review of 200 published prospective studies. Mayo Clin Proc 81:1159-1171, 2006
PubMed
19) Mermel LA:Short-term peripheral venous catheter-related bloodstream infections:a systematic review. Clin Infect Dis 65:1757-1762, 2017
PubMed
20) Loubani OM, Green RS:A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. J Crit Care 30:653 e9-17, 2015
 
21) O'Grady NP, Alexander M, Dellinger EP et al:Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 23:759-769, 2002
PubMed
22) Rickard CM, Webster J, Wallis MC et al:Routine versus clinically indicated replacement of peripheral intravenous catheters:a randomised controlled equivalence trial. Lancet 380:1066-1074, 2012
PubMed
23) Webster J, Osborne S, Rickard CM et al:Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev 8:CD007798, 2015
PubMed
24) Saint S, Greene MT, Krein SL et al:Aprogram to prevent catheter-associated urinary tract infection in Acute Care. N Engl J Med 374:2111-2119, 2016
 
P.110 掲載の参考文献
1) 日本呼吸器学会NPPVガイドライン作成委員会 編:NPPV(非侵襲的陽圧換気療法)ガイドライン 改訂第2版. 南江堂, p170, 2015
 
2) Akashiba T, Ishikawa Y, Ishihara H et al:The Japanese respiratory society noninvasive positive pressure ventilation(NPPV)guidelines(second revised edition). Respir Investig 55:83-92, 2017
 
3) Jolliet P, Ouanes-Besbes L, Abroug F et al(E. C. H. O. ICU Trial Investigators):A multicenter randomized trial assessing the efficacy of helium/oxygen in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 195:871-880, 2017
 
4) Abroug F, Ouanes-Besbes L, Hammouda Z et al:Noninvasive ventilation with heliumoxygen mixture in hypercapnic COPD exacerbation:aggregate meta-analysis of randomized controlled trials. Ann Intensive Care 7:59, 2017
PubMed
5) Stefan MS, Nathanson BH, Lagu T et al:Outcomes of noninvasive and invasive ventilation in patients hospitalized with asthma exacerbation. Ann Am Thorac Soc 13:1096-1104, 2016
PubMed
6) Luo Z, Han F, Li Y et al:Risk factors for noninvasive ventilation failure in patients with acute cardiogenic pulmonary edema:a prospective, observational cohort study. J Crit Care 39:238-247, 2017
PubMed
7) Hernandez G, Vaquero C, Colinas L et al:Effect of postextubation high-flow nasal cannula vs noninvasive ventilation on reintubation and postextubation respiratory failure in high-risk patients:a randomized clinical trial. JAMA 316:1565-1574, 2016
PubMed
8) Hernandez G, Vaquero C, Gonzalez P et al:Effect of postextubation high-flow nasal cannula vs conventional oxygen therapy on reintubation in low-risk patients:a randomized clinical trial. JAMA 315:1354-1361, 2016
PubMed
9) Futier E, Paugam-Burtz C, Godet T et al(OPERA study investigators):Effectof early postextubation high-flow nasal cannula vs conventional oxygen therapy on hypoxaemia in patients after major abdominal surgery:a French multicentre randomised controlled trial(OPERA). Intensive Care Med 42:1888-1898, 2016
 
10) Fernandez R, Subira C, Frutos-Vivar F et al:High-flow nasal cannula to prevent postextubation respiratory failure in high-risk non-hypercapnic patients:a randomized multicenter trial. Ann Intensive Care 7:47, 2017
PubMed
11) Jiang C, Esquinas A and Mina B:Evaluation of cough peak expiratory flow as a predictor of successful mechanical ventilationdiscontinuation:a narrative review of the literature. J Intensive Care 5:33, 2017
PubMed
12) Kutchak FM, Debesaitys AM, Rieder Mde M et al:Reflex cough PEF as a predictor of successful extubation in neurological patients. J Bras Pneumol 41:358-364, 2015
PubMed
13) Duan J, Zhou L, Xiao M et al:Semiquantitative cough strength score for predicting reintubation after planned extubation. Am J Crit Care 24:e86-90, 2015
 
14) Pieczkoski SM, Margarites AGF, Sbruzzi G:Noninvasive ventilation during immediate postoperative period in cardiac surgery patients:systematic review and metaanalysis. Braz J Cardiovasc Surg 32:301-311, 2017
PubMed
15) Jaber S, Lescot T, Futier E et al:Effect of noninvasive ventilation on tracheal reintubation among patients with hypoxemic respiratory failure following abdominal surgery:a randomized clinical trial. JAMA 315:1345-1353, 2016
PubMed
16) Faria DA, da Silva EM, Atallah AN et al:Noninvasive positive pressure ventilation for acute respiratory failure following upper abdominal surgery. Cochrane Database Syst Rev CD009134, 2015
PubMed
17) Carron M, Zarantonello F, Tellaroli P et al:Perioperative noninvasive ventilation in obese patients:a qualitative review and meta-analysis. Surg Obes Relat Dis 12:681-691, 2016
PubMed
18) Lemiale V, Mokart D, Resche-Rigon M et al:Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure:a randomized clinical trial. JAMA 314:1711-1719, 2015
PubMed
19) Bellani G, Laffey JG, Pham T et al:Noninvasive ventilation of patients with acute respiratory distress syndrome. insights from the LUNG SAFE study. Am J Respir Crit Care Med 195:67-77, 2017
PubMed
20) Nicolini A, Ferraioli G, Ferrari-Bravo M et al:Early non-invasive ventilation treatment for respiratory failure due to severe community-acquired pneumonia. Clin Respir J 10:98-103, 2016
PubMed
21) Korang SK, Feinberg J, Wetterslev J et al:Non-invasive positive pressure ventilation for acute asthma in children. Cochrane Database Syst Rev CD012067, 2016
PubMed
22) Morley SL:Non-invasive ventilation in paediatric critical care. Paediatr Respir Rev 20:24-31, 2016
PubMed
P.116 掲載の参考文献
1) Zieleskiewicz L, Muller L, Lakhal K et al:Point-of-care ultrasound in intensive care units:assessment of 1073 procedures in a multicentric, prospective, observational study. Intensive Care Med 41:1638-1647, 2015
 
2) Frankel HL, Kirkpatrick AW, Elbarbary M et al:Guidelines for the appropriate use of bedside general and cardiac ultrasonography in the evaluation of critically ill patients-Part I:general ultrasonography. Crit Care Med 43:2479-2502, 2015
PubMed
3) Levitov A, Frankel HL, Blaivas M et al:Guidelines for the appropriate use of bedside general and cardiac ultrasonography in the evaluation of critically ill patients-part II:cardiac ultrasonography. Crit Care Med 44:1206-1227, 2016
PubMed
4) Beaulieu Y, Laprise R, Drolet P et al:Bedside ultrasound training using webbased e-learning and simulation early in the curriculum of residents. Crit Ultrasound J 7:1, 2015
PubMed
5) Ramsingh D, Frank E, Haughton R et al:Auscultation versus point-of-care ultrasound to determine endotracheal versus bronchial intubation:a diagnostic accuracy study. Anesthesiology 124:1012-1020, 2016
PubMed
6) Kimura BJ:Point-of-care cardiac ultrasound techniques in the physical examination:better at the bedside. Heart 103:987-994, 2017
PubMed
7) Mantuani D, Frazee BW, Fahimi J et al:Point-of-care multi-organ ultrasound improves diagnostic accuracy in adults presenting to the emergency department with acute dyspnea. West J Emerg Med 17:46-53, 2016
 
8) Gallard E, Redonnet JP, Bourcier JE et al:Diagnostic performance of cardiopulmonary ultrasound performed by the emergency physician in the management of acute dyspnea. Am J Emerg Med 33:352-358, 2015
PubMed
9) Zanobetti M, Scorpiniti M, Gigli C et al:Point-of-care ultrasonography for evaluation of acute dyspnea in the ED. Chest 151:1295-1301, 2017
PubMed
10) Kobal SL, Liel-Cohen N, Shimony S et al:Impact of pont-of-care ultrasound examination on triage of patients with suspect cardiac disease. Am J Cardiol 118:1583-1587, 2016
 
11) Bouhemad B, Mongodi S, Via G et al:Ultrasound for"lung monitoring"of ventilated patients. Anesthesiology 122:437-447, 2015
PubMed
12) Sriram KB, Singh M:Lung ultrasound B-lines in exacerbations of chronic obstructive pulmonary disease. Intern Med J 47:324-327, 2017
PubMed
13) Enghard P, Rademacher S, Nee J et al:Simplified lung ultrasound protocol shows excellent prediction of extravascular lung water in ventilated intensive care patients. Crit Care 19:36, 2015
 
14) Alzahrani SA, Al-Salamah MA, Al-Madani WH et al:Systematic review and metaanalysis for the use of ultrasound versus radiology in diagnosing of pneumonia. Crit Ultrasound J 9:6, 2017
 
15) Pereda MA, Chavez MA, Hooper-Miele CC et al:Lung ultrasound for the diagnosis of pneumonia in children:a meta-analysis. Pediatrics 135:714-722, 2015
PubMed
16) Ellington LE, Gilman RH, Chavez MA et al:Lung ultrasound as a diagnostic tool for radiographically-confirmed pneumonia in low resource settings. Respir Med 128:57-64, 2017
PubMed
17) Mongodi S, Via G, Girard M et al:Lung ultrasound for early diagnosis of ventilator-associated pneumonia. Chest 149:969-980, 2016
PubMed
18) Murthi SB, Fatima S, Menne AR et al:Ultrasound assessment of volume responsiveness in critically ill surgical patients:two measurements are better than one. J Trauma Acute Care Surg 82:505-511, 2017
 
19) de Oliveira OH, Freitas FG, Ladeira RT et al:Comparison between respiratory changes in the inferior vena cava diameter and pulse pressure variation to predict fluid responsiveness in postoperative patients. J Crit Care 34:46-49, 2016
PubMed
20) Vignon P, Repesse X, Begot E et al:Comparison of echocardiographic indices used to predict fluid responsiveness in ventilated patients. Am J Respir Crit Care Med 195:1022-1032, 2017
PubMed
21) Kristensen MS, Teoh WH, Rudolph SS et al:A randomised cross-over comparison of the transverse and longitudinal techniques for ultrasound-guided identification of the cricothyroid membrane in morbidly obese subjects. Anaesthesia 71:675-683, 2016
PubMed
22) Gobatto AL, Besen BA, Tierno PF et al:Comparison between ultrasoundand bronchoscopy-guided percutaneous dilational tracheostomy in critically ill patients:a retrospective cohort study. J Crit Care 30:220.e13-7, 2015
 
23) Gobatto AL, Besen BA, Tierno PF et al:Ultrasound-guided percutaneous dilational tracheostomy versus bronchoscopy-guided percutaneous dilational tracheostomy in critically ill patients(TRACHUS):a randomized noninferiority controlled trial. Intensive Care Med 42:342-351, 2016
PubMed
24) Ravi PR, Vijay MN:Real time ultrasoundguided percutaneous tracheostomy:is it a better option than bronchoscopic guided percutaneous tracheostomy? Med J Armed Forces India 71:158-164, 2015
PubMed
25) Chacko J, Gagan B, Kumar U et al:Realtime ultrasound guided percutaneous dilatational tracheostomy with and without bronchoscopic control:an observational study. Minerva Anestesiol 81:166-174, 2015
PubMed
26) Sangwan YS, Chasse R:A modified technique for percutaneous dilatational tracheostomy:a retrospective review of 60 cases. J Crit Care 31:144-149, 2016
 
27) Umbrello M, Formenti P, Longhi D et al:Diaphragm ultrasound as indicator of respiratory effort in critically ill patients undergoing assisted mechanical ventilation:a pilot clinical study. Crit Care 19:161, 2015
 
28) Zambon M, Greco M, Bocchino S et al:Assessment of diaphragmatic dysfunction in the critically ill patient with ultrasound:a systematic review. Intensive Care Med 43:29-38, 2017
PubMed
P.122 掲載の参考文献
1) Miller PE, SolomonMA, McAreavey D:Advanced percutaneous mechanical circulatory support devices for cardiogenic shock. Critical Care Medicine 45:1922-1929, 2017
PubMed
2) Thiagarajan RR, Barbaro RP, Rycus PT et al:Extracorporeal life support organization registry international report 2016. ASAIO Journal 63:60-67, 2017
PubMed
3) Schmidt M, Burrell A, Roberts L et al:Predicting survival after ECMO for refractory cardiogenic shock:survival after veno-arterial-ECMO(SAVE)-score. European Heart Journal 36:2246-2256, 2015
PubMed
4) Khorsandi M, Dougherty S, Bouamra O et al:Extra-corporeal membrane oxygenation for refractory cardiogenic shock after adult cardiac surgery:a systemic review and meta-analysis. Journal of Cardiothoracic Surgery 12:55, 2017
 
5) Nagpal AD, Singal RK, Arora RC et al:Temporary mechanical circulatory support in cardiac critical care:a state of the art review and algorithm for decision selection. Canadian Journal of Cardiology 33:110-118, 2017
 
6) Hou X, Yang X, Du Z et al:Superior vena cava drainage improves upper body oxygenation during veno-arterial extracorporeal membrane oxygenation in sheep. Crit Care 19:68, 2015
 
7) Jayaraman AL, Cormican D, Shah P et al:Cannulation strategies in adult veno-arterial and veno-venous extracorporeal membrane oxygenation:techniques, limitations, and special considerations. Annals of Cardiac Anaesthesia 20:11-18, 2017
 
8) Sakamoto T, Morimura N, Nagao K et al:Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with out-of-hospital cardiac arrest:a prospective observational study. Resuscitation 85:762-768, 2014
PubMed
9) Stub D, Bernard S, Pellegrino V et al:Refractory cardiac arrest with mechanical CPR, hypothermia, ECMO and early reperfusion(the CHEER trial). Resuscitation 86:88-94, 2015
PubMed
10) Lamhaut L, Hutin A, Deutsch J et al:Extracorporeal cardiopulmonary resuscitation(ECPR)in the prehospital settings:an illustrative case of ECPR performed in the louvre museum. Prehospital Emergency Care 21:386-389, 2017
PubMed
11) Lamhaut L, Hutin A, Puymirat E et al:A pre-hospital extracorporeal cardio pulmonary resuscitation(ECPR)strategy for treatment of refractory out hospital cardiac arrest:an observational study and propensity analysis. Resuscitation 117:109-117, 2017
PubMed
12) Thiele H, Zeymer U, Neumann FJ et al:Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367:1287-1296, 2012
PubMed
13) American College of Emergency P, Society for Cardiovascular A, Interventions, O'Gara PT, Kushner FG, Ascheim DD, et al:2013 ACCF/AHA guideline for the management of ST-elevation myo- cardial infarction:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61:e78-140, 2013
 
14) Unverzagt S, Buerke M, de Waha A et al:Intra-aortic balloon pump counterpulsation(IABP)for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev 3:CD007398, 2015
PubMed
15) Ponikowski P, Voors AA, Anker SD et al:2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC)developed with the special contribution of the Heart Failure Association(HFA)of the ESC. Eur Heart J 37:2129-2200, 2016
 
16) Breschot N, Demondion P, Santi F et al:Intra-aortic balloon pump protects against hydrostatic pulmonary edema during peripheral venoarterial-extracorporeal membrane oxygenation. Eur Heart J Acute Cardiovasc Care, 2017 Jun 1[Epub aheadof print]
 
17) Aso S, Matsui H, Fushimi K et al:The effect of intraaortic balloon pumping under venoarterial extracorporeal membrane oxygenation on mortality of cardiogenic patients:an analysis using a nationwide inpatient database. Critical Care Medicine 44:1974-1979, 2016
PubMed
18) 中田 淳:ショックバイタルへの新しい循環補助Impellaの理論と有効性. 最新医学 71:1699-1709, 2016
Medical*Online
19) 日本アビオメッド社ホームページ. http://abiomed.co.jp/
 
20) 日本胸部外科学会ホームページ. http://www.jpats.org/
 
21) O'Neill WW, Schreiber T, Wohns DH et al:The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock:results from the USpella registry. J Interven Cardiol 27:1-11, 2014
 
22) Griffith BP, Anderson MB, Samuels ME et al:The RECOVER I:a multi-center prospective study of Impella 5.0/LD for postcardiotomy circulatory support. J Thorac Cardiovasc Surg 145:548-554, 2013
 
23) Moazzami K, Dolmatova E, Cocke TP et al:Left ventricular mechanical support with the Impella during extracorporeal membrane oxygenation. J Teh Univ Heart Ctr 12:11-14, 2017
 
P.127 掲載の参考文献
1) Gaudry S, Hajage D, Schortgen F et al:Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375:122-133, 2016
PubMed
2) Zarbock A, Kellum JA, Schmidt C et al:Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury:the ELAIN randomized clinical trial. JAMA 315:2190-2199, 2016
PubMed
3) Wierstra BT, Kadri S, Alomar S et al:The impact of "early" versus "late" initiation of renal replacement therapy in critical care patients with acute kidney injury:a systematic review and evidence synthesis. Crit Care 20:122, 2016
PubMed
4) Xu Y, Gao J, Zheng X et al:Timing of initiation of renal replacement therapy for acute kidney injury:a systematic review and meta-analysis of randomized-controlled trials. Clin Exp Nephrol 21:552-562, 2017
PubMed
5) Smith OM, Wald R, Adhikari NK et al:Standard versus accelerated initiation of renal replacement therapy in acute kidney injury(STARRT-AKI):study protocol for a randomized controlled trial. Trials 14:320, 2013
PubMed
6) Barbar SD, Binquet C, Monchi M et al:Impact on mortality of the timing of renal replacement therapy in patients with severe acute kidney injury in septic shock:the IDEAL-ICU study(initiationof dialysis early versus delayed in the intensive care unit):study protocol for a randomized controlled trial. Trials 15:270, 2014
 
7) Arimura T, Abe M, Shiga H et al:Clinical study of blood purification therapy in critical care in Japan:results from the survey research of the Japan Society for Blood Purification in Critical Care in 2013. J Artif Organs 20:244-251, 2017
 
8) Zhang L, Yang J, Eastwood GM et al:Extended daily dialysis versus continuous renal replacement therapy for acute kidney injury:a meta-analysis. Am J Kidney Dis 66:322-330, 2015
 
9) Nash DM, Przech S, Wald R et al:Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit. J Crit Care 41:138-144, 2017
PubMed
10) Truche AS, Darmon M, Bailly S et al:Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients:impact on mortality and renal recovery. Intensive Care Med 42:1408-1417, 2016
PubMed
11) Vanholder R, Van Biesen W, Hoste E et al:Pro/con debate:continuous versus intermittent dialysis for acute kidney injury:a never-ending story yet approaching the finish? Crit Care 15:204, 2011
PubMed
12) Ronco C, Bellomo R, Homel P et al:Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure:a prospective randomised trial. Lancet 356:26-30, 2000
PubMed
13) Fayad AI, Buamscha DG, Ciapponi A:Intensity of continuous renal replacement therapy for acute kidney injury. Cochrane Database Syst Rev 10:CD010613, 2016
PubMed
14) Park JT, Lee H, Kee YK et al:High-dose versus conventional-dose continuous venovenous hemodiafiltration and patient and kidney survival and cytokine removal in sepsis-associated acute kidney injury:a randomized controlled trial. Am J Kidney Dis 68:599-608, 2016
 
15) Mayumi K, Yamashita T, Hamasaki Y et al:Impact of continuous renal replacement therapy intensity on septic acute kidney injury. Shock 45:133-138, 2016
PubMed
16) Clark WR, Leblanc M, Ricci Z et al:Quantification and dosing of renal replacement therapy in acute kidney injury:a reappraisal. Blood Purif 44:140-155, 2017
PubMed
17) Nagata I, Uchino S, Tokuhira N et al:Sepsis may not be a risk factor for mortality in patients with acute kidney injury treated with continuous renal replacement therapy. J Crit Care 30:998-1002, 2015
 
18) Shiga H, Hirasawa H, Nishida O et al:Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock:a preliminary report. Blood Purif 38:211-218, 2014
PubMed
19) Hara Y, Shimomura Y, Nakamura T et al:Novel blood purification system for regulating excessive immune reactions in severe sepsis and septic shock:an ex vivo pilot study. Ther Apher Dial 19:308-315, 2015
 
20) Doi K, Iwagami M, Yoshida E et al:Associations of polyethylenimine-coated AN69ST membrane in continuous renal replacement therapy with the intensive care outcomes:observations from a claims database from Japan. Blood Purif 44:184-192, 2017
PubMed
21) Cruz DN, Antonelli M, Fumagalli R et al:Early use of polymyxin B hemoperfusion in abdominal septic shock:the EUPHAS randomized controlled trial. JAMA 301:2445-2452, 2009
PubMed
22) Payen DM, Guilhot J, Launey Y et al:Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis:a multicenter randomized control trial. Intensive Care Med 41:975-984, 2015
PubMed
23) Shimizu T, Miyake T, Kitamura N et al:Endotoxin adsorption:direct hemoperfusion with the polymyxin B-immobilized fiber column(PMX). Transfus Apher Sci 56:682-688, 2017
PubMed
24) Iba T, Fowler L:Is polymyxin B-immobilized fiber column ineffective for septic shock? a discussion on the press release for EUPHRATES trial. J Intensive Care 5:40, 2017
 
25) Cutuli SL, Artigas A, Fumagalli R et al:Polymyxin-B hemoperfusion in septic patients:analysis of a multicenter registry. Ann Intensive Care 6:77, 2016
PubMed
26) Iwagami M, Yasunaga H, Noiri E et al:Potential survival benefit of polymyxin B hemoperfusion in septic shock patients on continuous renal replacement therapy:a propensity-matched analysis. Blood Purif 42:9-17, 2016
PubMed
27) Nakamura Y, Kitamura T, Kiyomi F et al:Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock:a propensity-matched cohort study. Crit Care 21:134, 2017
PubMed
28) Saito N, Sugiyama K, Ohnuma T et al:Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection. PLoS One 12:e0173633, 2017
PubMed
P.135 掲載の参考文献
1) Schuetz P, Birkhahn R, Sherwin R et al:Serial procalcitonin predicts mortality in severe sepsis patients:results from the multicenter procalcitonin monitoring sepsis(MOSES) Study. Crit Care Med 45:781-789, 2017
PubMed
2) Trasy D, Molnar Z:Procalcitonin - assisted antibiotic strategy in sepsis. EJIFCC 28:104-113, 2017
PubMed
3) de Jong E, van Oers JA, Beishuizen A et al:Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients:a randomised, controlled, open-label trial. Lancet Infect Dis 16:819-827, 2016
PubMed
4) Liu Y, Hou JH, Li Q et al:Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome:a systematic review and meta-analysis. Springerplus 5:2091, 2016
PubMed
5) Klouche K, Cristol JP, Devin J et al:Diagnostic and prognostic value of soluble CD14 subtype(Presepsin)for sepsis and community-acquired pneumonia in ICU patients. Ann Intensive Care 6:59, 2016
PubMed
6) Bomberg H, Klingele M, Wagenpfeil S et al:Presepsin (sCD14-ST) is a novel marker for risk stratification in cardiac surgery patients. Anesthesiology 126:631-642, 2017
PubMed
7) Song X, Song Y, Yuan Y et al:Prognostic value of presepsin for outcomes and complications in enterocutaneous fistula complicated by abdominal sepsis. Int J Surg 33 Pt A:96-101, 2016
 
8) Rios-Toro JJ, Marquez-Coello M, Garcia-Alvarez JM et al:Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock. PLoS One 12:e0175254, 2017
 
9) Ricarte-Bratti JP, Brizuela NY, Jaime-Albarran N et al:IL-6, MMP3 and prognosis in previously healthy sepsis patients. Rev Fac Cien Med Univ Nac Cordoba 74:99-106, 2017
PubMed
10) Karampela I, Kandri E, Antonakos G et al:Kinetics of circulating fetuin-A may predict mortality independently from adiponectin, high molecular weight adiponectin and prognostic factors in critically ill patients with sepsis:a prospective study. J Crit Care 41:78-85, 2017
PubMed
11) Jia HM, Huang LF, Zheng Y et al:Diagnostic value of urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor binding protein 7 for acute kidney injury:a meta-analysis. Crit Care 21:77, 2017
PubMed
12) Honore PM, Nguyen HB, Gong M et al:Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 for risk stratification of acute kidney injury in patients with sepsis. Crit Care Med 44:1851-1860, 2016
PubMed
13) Koyner JL, Shaw AD, Chawla LS et al:Tissue Inhibitor Metalloproteinase-2(TIMP-2) IGF-Binding Protein-7(IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI. J Am Soc Nephrol 26:1747-1754, 2015
 
14) Jabaudon M, Blondonnet R, Roszyk L et al:Soluble receptor for advanced glycation end-products predicts impaired alveolar fluid clearance in acute respiratory distress syndrome. Am J Respir Crit Care Med 192:191-199, 2015
PubMed
15) Mrozek S, Jabaudon M, Jaber S et al:Elevated plasma levels of sRAGE are associated with nonfocal CT-based lung imaging in patients with ARDS:a prospective multicenter study. Chest 150:998-1007, 2016
PubMed
16) Jabaudon M, Godet T, Futier E et al:Rationale, study design and analysis plan of the lung imaging morphology for ventilator settings in acute respiratory distress syndrome study (LIVE study):study protocol for a randomised controlled trial. Anaesth Crit Care Pain Med, 2017 Mar 19[Epub ahead of print]
 
17) Ware LB, Koyama T, Billheimer DD et al:Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 137:288-296, 2010
PubMed
18) Zhao Z, Wickersham N, Kangelaris KN et al:External validation of a biomarker and clinical prediction model for hospital mortality in acute respiratory distress syndrome. Intensive Care Med 43:1123-1131, 2017
PubMed
19) Asakura H, Takahashi H, Uchiyama T et al:Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J 14:42, 2016
PubMed
20) Toh CH, Alhamdi Y, Abrams ST:Current pathological and laboratory considerations in the diagnosis of disseminated intra-vascular coagulation. Ann Lab Med 36:505-512, 2016
 
21) Singh N, Pati HP, Tyagi S et al:Evaluation of the diagnostic performance of fibrin monomer in comparison to D-dimer in patients with overt and nonovert disseminated intravascular coagulation. Clin Appl Thromb Hemost 23:460-465, 2017
 
22) Lee DH, Lee BK, Noh SM et al:High fibrin/fibrinogen degradation product to fibrinogen ratio is associated with 28-day mortality and massive transfusion in severe trauma. Eur J Trauma Emerg Surg, 2017 Sep 18[Epub ahead of print]
 
23) Endo A, Shiraishi A, Otomo Y et al:Development of novel criteria of the "Lethal Triad" as an indicator of decision making in current trauma care:a retrospective multicenter observational study in Japan. Crit Care Med 44:e797-803, 2016
PubMed
24) Sugimoto K, Suehiro E, Shinoyama M et al:D-dimer elevation as a blood biomarker for detection of structural disorder in mild traumatic brain injury. J Neurotrauma, 2017 Sep 12[Epub ahead of print]
 
P.142 掲載の参考文献
1) Bernard SA, Gray TW, Buist MD et al:Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346:557-563, 2002
PubMed
2) Hypothermia after Cardiac Arrest Study Group:Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346:549-556, 2002
 
3) Nielsen N, Wetterslev J, Cronberg T et al:Target temperature management at 33℃ versus 36℃ after cardiac arrest. N Engl J Med 369:2197-2206, 2013
 
4) 一般社団法人日本蘇生協議会監修:JRC蘇生ガイドライン2015, 医学書院, 2016
 
5) Nielsen N:The target temperature for post cardiac arrest patients should be 36℃. Crit Care Med 45:1552-1554, 2017
 
6) Frydland M, Kjaergaard J, Erlinge D et al:Target temperature management of 33℃ and 36℃ in patients with out-of-hospital cardiac arrest with initial non-shockable rhythm:a TTM sub-study. Resuscitation 89:142-148, 2015
 
7) Moler FW, Silverstein FS, Holubkov R et al:Therapeutic hypothermia after out-of-hospital cardiac arrest in children. N Engl J Med 372:1898-1908, 2015
PubMed
8) Moler FW, Silverstein FS, Holubkov R et al:Therapeutic hypothermia after in hospital cardiac arrest in children. N Engl J Med 376:318-329, 2017
PubMed
9) Chan PS, Berg RA, Tang Y et al:Association between therapeutic hypothermia and survival after in-hospital cardiac arrest. JAMA 316:1375-1382, 2016
PubMed
10) Cronberg T, Lilja G, Hom J et al:TTM trial investigators:neurologic function and health-related quality of life in patients following targeted temperature management at 33℃ vs 36℃ after out-of-hospital cardiac arrest:a randomized clinical trial. JAMA Neurol 72:634-641, 2015
 
11) Lilja G, Nielsen N, Friberg H et al:Cognitive function in survivors of out-of-hospital cardiac arrest after target temperature management at 33℃ versus 36℃. Circulation 131:1340-1349, 2015
 
12) Stammet P, Collignon O, Hassager C et al:Neuron-specific enolase as a predictor of death or poor neurological outcome after out-of-hospital cardiac arrest and targeted temperature management at 33℃ and 36℃. J Am Coll Cardiol 65:2104-2114, 2015
 
13) Bray JE, Stub D, Bloom JE et al:Changing target temperature from 33℃ to 36℃ in the ICU management of out-of-hospital cardiac arrest:a before and after study. Resuscitation 113:39-43, 2017
 
14) Casamento A, Minson A, Radford S et al:A comparison of therapeutic hypothermia and strict therapeutic normothermia after cardiac arrest. Resuscitation 106:83-88, 2016
 
15) Kirkegaard H, Soreide E, de Haas I et al:Targeted temperature management for 48 vs 24 hours and neurologic outcome after out-of-hospital cardiac arrest:a randomized clinical trial. JAMA 318:341-350, 2017
PubMed
16) Hifumi T, Kuroda Y, Kawakita K et al:Effect of admission glasgow coma scale motor score on neurological outcome in out-of-hospital cardiac arrest patients receiving therapeutic hypothermia. Circ J 79:2201-2208, 2015
PubMed
17) Oh SH, Park KN, Shon YM et al:Continuous amplitude-integrated electro-encephalographic monitoring is a useful prognostic tool for hypothermia-treated cardiac Arrest Patients. Circulation 132:1094-1103, 2015
 
18) Sugiyama K, Kashiura M, Akashi A et al:Prognostic value of the recovery time of continuous normal voltage in amplitude-integrated electroencephalography in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia:a retrospective study. J Intensive Care 4:25, 2016
PubMed
19) Lee KS, Lee SE, Choi JY et al:Useful computed tomography score for estimation of early neurologic outcome in post-cardiac arrest patients with therapeutic hypothermia. Circ J, 2017 Jun 6[Epub ahead of print]
 
20) Nishiyama K, Ito N, Orita T et al:Regional cerebral oxygen saturation monitoring for predicting interventional outcomes in patients following out-of-hospital cardiac arrest of presumed cardiac cause:a prospective, observational, multicenter study. Resuscitation 96:135-141, 2015
 
P.147 掲載の参考文献
1) Andersen LW, Raymond TT, Berg RA et al:Association between tracheal intubation during pediatric in-hospital cardiac arrest and survival. JAMA 316:1786-1797, 2016
PubMed
2) Andersen LW, Granfeldt A, Callaway CW et al:Association between tracheal intubation during adult in-hospital cardiac arrest and survival. JAMA 317:494-506, 2017
PubMed
3) Kang K, Kim T, Ro YS et al:Prehospital endotracheal intubation and survival after out-of-hospital cardiac arrest:results from the Korean nationwide registry. Am J Emerg Med 34:128-132, 2016
PubMed
4) Jeong S, Ahn KO, Shin SD:The role of prehospital advanced airway management on outcomes for out-of-hospital cardiac arrest patients:a meta-analysis. Am J Emerg Med 34:2101-2106, 2016
PubMed
5) Higgs A, Cook TM, McGrath BA:Airway management in the critically ill:the same, but different. Br J Anaesth 117(Suppl 1):i5-i9, 2016
 
6) Natt BS, Malo J, Hypes CD et al:Strategies to improve first attempt success at intubation in critically ill patients. Br J Anaesth 117(Suppl 1):i60-i68, 2016
 
7) Mosier JM, Sakles JC, Stolz U et al:Neuromuscular blockade improves first-attempt success for intubation in the intensive care unit. a propensity matched analysis. Ann Am Thorac Soc 12:734-741, 2015
PubMed
8) Mercer SJ, Jones CP, Bridge M et al:Systematic review of the anaesthetic management of non-iatrogenic acute adult airway trauma. Br J Anaesth 117(Supple 1):i49-i59, 2016
 
9) Hypes CD, Stolz U, Sakles JC et al:Video laryngoscopy improves odds of first-attempt success at intubation in the intensive care unit. a propensity-matched analysis. Ann Am Thorac Soc 13:382-390, 2016
PubMed
10) Janz DR, Semler MW, Lentz RJ et al:Randomized trial of video laryngoscopy for endotracheal intubation of critically ill adults. Crit Care Med 44:1980-1987, 2016
PubMed
11) Lascarrou JB, Boisrame-Helms J, Bailly A et al:Video laryngoscopy vs direct laryngoscopy on successful first-pass orotracheal intubation among ICU patients:a randomized clinical trial. JAMA 317:483-493, 2017
PubMed
12) Asai T:Avoiding repeated attempts at tracheal intubation-can videolaryngoscopes be the answer? Anesthesiology 125:615-617, 2016
PubMed
13) Aziz MF, Bayman EO, Van Tienderen MM et al:Predictors of difficult videolaryngoscopy with GlideScope(R) or C-MAC(R) with D-blade:secondary analysis from a large comparative videolaryngoscopy trial. Br J Anaesth 117:118-123, 2016
 
14) Joshi R, Hypes CD, Greenberg J et al:Difficult airway characteristics associated with first-attempt failure at intubation using video laryngoscopy in the intensive care unit. Ann Am Thorac Soc 14:368-375, 2017
PubMed
15) Su K, Gao X, Xue FS et al:Difficult tracheal tube passage and subglottic airway injury during intubation with the GlideScope(R) videolaryngoscope:a randomised, controlled comparison of three tracheal tubes. Anaesthesia 72:504-511, 2017
 
16) Komasawa N, Kido H, Miyazaki Y et al:Cricoid pressure impedes tracheal intubation with the Pentax-AWSA irwayscope(R):a prospective randomized trial. Br J Anaesth 116:413-416, 2016
 
17) Asai T:Videolaryngoscopes:do they have role during rapid-sequence induction of anaesthesia? Br J Anaesth 116:317-319, 2016
PubMed
18) Ota K, Sadamori T, Kusunoki S et al:Influence of clinical experience of the Macintosh laryngoscope on performance with the Pentax-AWS Airway Scope((R)), a rigid video-laryngoscope, by paramedics in Japan. J Anesth 29:672-677, 2015
 
19) Asai T:Are video laryngoscopes useful for paramedics during cardiopulmonary resuscitation? J Anesth 29:651-653, 2015
PubMed
20) Frerk C, Mitchell VS, McNarry AF et al:Difficult airway society 2015 guidelines for management of unanticipated difficult intubation in adults. Br J Anaesth 115:827-848, 2015
 
21) Mushambi MC, Kinsella SM, Popat M et al:Obstetric Anaesthetists' Association and Difficult Airway Society guidelines for the management of difficult and failed tracheal intubation in obstetrics. Anaesthesia 70:1286-1306, 2015
 
22) Cook TM, Woodall N, Frerk C:A national survey of the impact of NAP4 on airway management practice in United Kingdom hospitals:closing the safety gap in anaesthesia, intensive care and the emergency department. Br J Anaesth 117:182-190, 2016
PubMed
23) Ono Y, Tanigawa K, Shinohara K et al:Difficult airway management resources and capnography use in Japanese intensive care units:a nationwide cross-sectional study. J Anesth 30:644-652, 2016
PubMed
24) Sturgess DJ, Greenland KB, Senthuran S et al:Tracheal extubation of the adult intensive care patient with a predicted difficult airway:a narrative review. Anaesthesia 72:248-261, 2017
PubMed
25) Mort TC, Braffett BH:Conventional versus video laryngoscopy for tracheal tube exchange:glottic visualization, success rates, complications, and rescue alternatives in the high-risk difficult airway patient. Anesth Analg 121:440-448, 2015
PubMed
26) Jaber S, Monnin M, Girard M et al:Apnoeic oxygenation via high-flow nasal cannula oxygen combined with non-invasive ventilation preoxygenation for intubation in hypoxaemic patients in the intensive care unit:the single-centre, blinded, randomised controlled OPTINIV trial. Intensive Care Med 42:1877-1887, 2016
PubMed
27) Ni YN, Luo J, Yu H et al:Can high-flow nasal cannula reduce the rate of endotracheal intubation in adult patients with acute respiratory failure compared with conventional oxygen therapy and noninvasive positive pressure ventilation?:a systematic review and meta-analysis. Chest 151:764-775, 2017
 
28) Hernandez G, Vaquero C, Gonzalez P et al:Effect of postextubation high-flow nasal cannula vs conventional oxygen therapy on reintubation in low-risk patients:a randomized clinical trial. JAMA 315:1354-1361, 2016
PubMed
29) Hernandez G, Vaquero C, Colinas L et al:Effect of postextubation high-flow nasal cannula vs noninvasive ventilation on reintubation and postextubation respiratory failure in high-risk patients:a randomized clinical trial. JAMA 316:1565-1574, 2016
PubMed

III章 ICU特有の病態・合併症

P.154 掲載の参考文献
1) 日本集中治療医学会:日本人工呼吸器関連肺炎予防バンドル2010 改訂版. 日本集中治療医学会, 2010.
 
2) P Gunasekera MF, A Gratrix MMFFF:Ventilator-associated pneumonia. British Journal of Anaesthesia 16:5, 2016
 
3) 渡邉 都:Ventilator-Associated Events(VAE)の疫学, 要因及び予防策. 日本環境感染学会誌 31:151-157, 2016
 
4) Bouadma L, Sonneville R, Garrouste-Orgeas M et al:Ventilator-associated events:prevalence, outcome, and relationship with ventilator-associated pneumonia. Crit Care Med 43:1798-806, 2016
 
5) Kalil AC, Metersky ML, Klompas M et al:Management of adults with hospital-acquired and ventilator-associated pneumonia:2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 63:e61-e111, 2016
 
6) Bozorgmehr R, Bahrani V, Fatemi A:Ventilator-associated pneumonia and its responsible germs:an epidemiological study. Emerg(Tehran)5:e26, 2017.
PubMed
7) Wang G, Ji X, Xu Y et al:Lung ultrasound:a promising tool to monitor ventilator-associated pneumonia in critically ill patients. Crit Care 20:320, 2016
 
8) Ory J, Raybaud E, Chabanne R et al:Comparative study of 2 oral care protocols in intensive care units. Am J Infect Control 45:245-250, 2017
PubMed
9) Chen Y, Mao EQ, Yang YJ et al:Prospective observational study to compare oral topical metronidazole versus 0.2% chlorhexidine gluconate to prevent nosocomial pneumonia. Am J Infect Control 44:1116-1122, 2016
 
10) Tang HJ, Chao CM, Leung PO et al:An observational study to compare oral hygiene care with chlorhexidine gluconate gel versus mouthwash to prevent ventilator-associated pneumonia. Infect Control Hosp Epidemiol 38:631-632, 2017
PubMed
11) 佐藤みえ, 山田 亨, 安岡砂織 他:人工呼吸管理中患者の頸部の姿勢および体幹との位置関係. 東邦看護学会誌 13:31-36, 2016
Medical*Online
12) Bassi GL, Xiol EA, Pagliara F et al:Body position and ventilator-associated pneumonia prevention. Semin Respir Crit Care Med 38:371-380, 2017
PubMed
13) Jaillette E, Girault C, Brunin G et al:Impact of tapered-cuff tracheal tube on microaspiration of gastric contents in intubated critically ill patients:a multicenter cluster-randomized cross-over controlled trial. Intensive Care Med, 2017 Mar 16[Epub ahead of print]
 
14) Ghoochani Khorasani A, Shadnia S, Mashayekhian M et al:Efficacy of hilo evac endotracheal tube in prevention of ventilator-associated pneumonia in mechanically ventilated poisoned patients. Scientifica(Cairo) 2016:4901026, 2016
PubMed
15) Yilmaz G, Aydin H, Aydin M et al:Staff education aimed at reducing ventilator-associated pneumonia. J Med Microbiol 65:1378-1384, 2016
PubMed
16) Alcan AO, Korkmaz FD, Uyar M:Prevention of ventilator-associated pneumonia:use of the care bundle approach. American Journal of Infection Control 44:E173-E6, 2016
 
17) DeLuca LA Jr, Walsh P, Davidson DD et al:Impact and feasibility of an emergency department-based ventilator-associated pneumonia bundle for patients intubated in an academic emergency department. Am J Infect Control 45:151-157, 2017
 
18) Safdar N, Musuuza JS, Xie A et al:Management of ventilator-associated pneumonia in intensive care units:a mixed methods study assessing barriers and facilitators to guideline adherence. BMC Infect Dis 16:349, 2016
PubMed
19) Yoshimura J, Kinoshita T, Yamakawa K et al:Impact of gram stain results on initial treatment selection in patients with ventilator-associated pneumonia:a retrospective analysis of two treatment algorithms. Crit Care 21:156, 2017
PubMed
20) Dureau AF, Duclos G, Antonini F et al:Rapid diagnostic test and use of antibiotic against methicillin-resistant Staphylococcus aureus in adult intensive care unit. Eur J Clin Microbiol Infect Dis 36:267-272, 2017
PubMed
21) Sbrana F, Malacarne P, Bassetti M et al:Risk factors for ventilator associated pneumonia due to carbapenemase-producing klebsiella pneumoniae in mechanically ventilated patients with tracheal and rectal colonization. Minerva Anestesiol 82:635-640, 2016
PubMed
22) Bassetti M, Welte T, Wunderink RG:Treatment of gram-negative pneumonia in the critical care setting:is the beta-lactam antibiotic backbone broken beyond repair? Crit Care 20:19, 2016
 
23) Ramirez P, Lopez-Ferraz C, Gordon M et al:From starting mechanical ventilation to ventilator-associated pneumonia, choosing the right moment to start antibiotic treatment. Crit Care 20:169, 2016
PubMed
24) Zilahi G, McMahon MA, Povoa P et al:Duration of antibiotic therapy in the intensive care unit. J Thorac Dis 8:3774-3780, 2016
PubMed
25) Vincent JL, Bassetti M, Francois B et al:Advances in antibiotic therapy in the critically ill. Crit Care 20:133, 2016
PubMed
26) Moraes RB, Guillen JA, Zabaleta WJ et al:De-escalation, adequacy of antibiotic therapy and culture positivity in septic patients:an observational study. Rev Bras Ter Intensiva 28:315-322, 2016
PubMed
27) Demirdal T, Sari US, Nemli SA:Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii? Ann Clin Microb Anti 15:11, 2016
PubMed
28) 原 祐樹, 川島 誠, 浅井幸江 他:海外で治療歴のある人工呼吸器関連肺炎患者より多剤耐性菌を検出した1症例. 日臨微生物誌 26:322-329, 2016
 
29) 伊藤雄介, 川崎達也, 松井 亨 他:小児集中治療室における人工呼吸器関連肺炎および人工呼吸器関連事象サーベイランス. 日集中医誌 22:417-420, 2015
 
30) 伊藤雄介:基礎疾患のある子どもの肺炎の治療方針 小児集中治療室における人工呼吸器関連肺炎. 日小児呼吸器会誌 28:103-108, 2017
 
P.160 掲載の参考文献
1) 3学会合同ARDS診療ガイドライン2016作成委員会:ARDS診療ガイドライン2016. http://www.jsicm.org/ARDSGL/ARDSGL2016.pdf
 
2) Fan E, Del Sorbo L, Goligher EC et al:An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline:Mechanical ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 195:1253-1263, 2017
PubMed
3) Bellani G, Laffey JG, Pham T et al:Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315:788-800, 2016
PubMed
4) Neto AS, Barbas CSV, Simonis FD et al:Epidemiological characteristics, practice ofventilation, and clinical outcome in patients atrisk of acute respiratory distress syndromein intensive care units from 16 countries(PRoVENT):an international, multicentre, prospective study. Lancet Respir Med 4:882-893, 2016
 
5) Dinglas VD, Aronson Friedman L, Colantuoni E et al:Muscle weakness and 5-year survival in acute respiratory distress syndrome survivors. Crit Care Med 45:446-453, 2017
PubMed
6) Brodsky MB, Huang M, Shanholtz C et al:Recovery from dysphagia symptoms after oral endotracheal intubation in acute respiratory distress syndrome survivors:a 5-year longitudinal study. Ann Am Thorac Soc 14:376-383, 2017
PubMed
7) Huang M, Parker AM, Bienvenu OJ et al:Psychiatric symptoms in acute respiratory distress syndrome survivors:a 1-year national multicenter study. Crit Care Med 44:954-965, 2016
PubMed
8) Cressoni M, Chiumello D, Algieri I et al:Opening pressures and atelectrauma in acute respiratory distress syndrome. Intensive Care Med 43:603-611, 2017
PubMed
9) Briel M, Meade M, Mercat A et al:Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome. JAMA 303:865-873, 2010
PubMed
10) Kacmarek RM, Villar J, Sulemanji D et al:Open lung approach for the acute respiratory distress syndrome:a pilot, randomized controlled trial. Crit Care Med 44:32-42, 2016
PubMed
11) Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial(ART)Investigators, Cavalcanti AB, Suzumura EA et al:Effect of lung recruitment and titrated positive end-expiratory pressure(PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome:a randomized clinical trial.JAMA 318:1335-1345, 2017
 
12) Costa Leme A, Hajjar LA, Volpe MS et al:Effect of intensive vs moderate alveolar recruitment strategies added to lung-protective ventilation on postoperative pulmonary complications:a randomized clinical trial. JAMA 317:1422-1432, 2017
PubMed
13) National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome(ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP et al:Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354:2564-2575, 2006
PubMed
14) Semler MW, Wheeler AP, Thompson BT et al:Impact of initial central venous pressure on outcomes of conservative versus liberal fluid management in acute respiratory distress syndrome. Crit Care Med 44:782-789, 2016
PubMed
15) Mekontso Dessap A, Boissier F, Charron C et al:Acute cor pulmonale during protective ventilation for acute respiratory distress syndrome:prevalence, predictors, and clinical impact. Intensive Care Med 42:862-870, 2016
PubMed
16) Guerin C, Reignier J, Richard JC et al:Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 368:2159-2168, 2013
PubMed
17) Ayzac L, Girard R, Baboi L et al:Ventilator-associated pneumonia in ARDS patients:the impact of prone positioning. a secondary analysis of the PROSEVA trial. Intensive Care Med 42:871-878, 2016
 
18) Nin N, Muriel A, Penuelas O et al:Severe hypercapnia and outcome of mechanically ventilated patients with moderate or severe acute respiratory distress syndrome. Intensive Care Med 43:200-208, 2017
 
19) Kangelaris KN, Ware LB, Wang CY et al:Timing of intubation and clinical outcomes in adults with acute respiratory distress syndrome. Crit Care Med 44:120-129, 2016
PubMed
20) Bellani G, Laffey JG, Pham T et al:Noninvasive ventilation of patients with acute respiratory distress syndrome:insights from the LUNG SAFE study. Am J Respir Crit Care Med 195:67-77, 2017
PubMed
21) Carteaux G, Millan-Guilarte T, De Prost N et al:Failure of noninvasive ventilation for de novo acute hypoxemic respiratory failure:role of tidal volume. Crit Care Med 44:282-290, 2016
 
22) Frat JP, Thille AW, Mercat A et al:High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 372:2185-2196, 2015
PubMed
23) Patel BK, Wolfe KS, Pohlman AS et al:Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome:a randomized clinical trial. JAMA 315:2435-2441, 2016
PubMed
24) Matthay MA, McAuley DF, Ware LB:Clinical trials in acute respiratory distress syndrome:challenges and opportunities. Lancet Respir Med 5:524-534, 2017
PubMed
25) Kor DJ, Carter RE, Park PK et al:Effect of aspirin on development of ARDS in atrisk patients presenting to the emergency department:the LIPS-A randomized clinical trial. JAMA 315:2406-2414, 2016
 
26) Wang L, Li H, Gu X et al:Effect of antiplatelet therapy on acute respiratory distress syndrome and mortality in critically ill patients:a meta-analysis. PLoS One 11:e0154754, 2016
 
27) Gajic O, Dabbagh O, Park PK et al:Early identification of patients at risk of acute lung injury:evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med 183:462-470, 2011
 
28) Thompson BT, Chambers RC, Liu KD:Acute respiratory distress syndrome. N Engl J Med 377:562-572, 2017
PubMed
29) Beitler JR, Goligher EC, Schmidt M et al:Personalized medicine for ARDS:the 2035 research agenda. Intensive Care Med 42:756-767, 2016
PubMed
30) Gibelin A, Parrot A, Maitre B et al:Acute respiratory distress syndrome mimickers lacking common risk factors of the Berlin definition. Intensive Care Med 42:164-172, 2016
PubMed
31) Calfee CS, Delucchi K, Parsons PE et al:Subphenotypes in acute respiratory distress syndrome:latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2:611-620, 2014
PubMed
32) Famous KR, Delucchi K, Ware LB et al:Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med 195:331-338, 2017
PubMed
33) Cardinal-Fernandez P, Bajwa EK, Dominguez-Calvo A et al:The presence of diffuse alveolar damage on open lung biopsy is associated with mortality in patients with acute respiratory distress syndrome:a systematic review and meta-analysis. Chest 149:1155-1164, 2016
PubMed
34) Luo L, Shaver CM, Zhao Z et al:Clinical predictors of hospital mortality differ between direct and indirect ARDS. Chest 151:755-763, 2017
PubMed
35) Mrozek S, Jabaudon M, Jaber S et al:Elevated plasma levels of sRAGE are associated with nonfocal CT-based lung imaging in patients with ARDS:a prospective multicenter study. Chest 150:998-1007, 2016
PubMed
P.167 掲載の参考文献
1) Ohashi-Fukuda N, Fukuda T, Yahagi N:Effect of pre-hospital advanced airway management for out-of-hospital cardiac arrest caused by respiratory disease:a propensity score-matched study. Anaesth Intensive Care 45:375-383, 2017
PubMed
2) Tanaka H, Ong MEH, Siddiqui FJ et al:PAROS Clinical Research Network. modifiable factors associated with survival after out-of-hospital cardiac arrest in the Pan-Asian resuscitation outcomes study. Ann Emerg Med, 2017[Epub ahead of print]
 
3) Ohashi-Fukuda N, Fukuda T, Doi K et al:Effect of prehospital advanced airway management for pediatric out-of-hospital cardiac arrest. Resuscitation 114:66-72, 2017
PubMed
4) Jarman AF, Hopkins CL, Hansen JN et al:Advanced airway type and its association with chest compression interruptions during out-of-hospital cardiac arrest resuscitation attempts. Prehosp Emerg Care 21:628-635, 2017
PubMed
5) Park MJ, Kwon WY, Kim K et al:Pre-hospital supraglottic airway was associated with good neurological outcome in cardiac arrest victims especially who received prolonged cardiopulmonary resuscitation. Acad Emerg Med, 2017[Epub ahead of print]
 
6) Pabst D, Brehm CE:Is pulseless electrical activity a reason to refuse cardiopulmonary resuscitation with ECMO support? Am J Emerg Med, 2017[Epub ahead of print]
 
7) Yamaguchi R, Makino Y, Chiba F et al:Frequency and influencing factors of cardiopulmonary resuscitation-related injuries during implementation of the American Heart Association 2010 Guidelines:a retrospective study based on autopsy and postmortem computed tomography. Int J Legal Med, 2017 Sep 13[Epub ahead of print]
 
8) Guenther SPW, Schirren M, Boulesteix AL et al:Effects of the Cardio First AngelTM on chest compression performance. Technol Health Care, 2017[Epub aheadof print]
 
9) Gyllenborg T, Granfeldt A, Lippert F etal:Quality of bystander cardiopulmonary resuscitation during real-life out-of-hospital cardiac arrest. Resuscitation 120:63-70, 2017 Sep 10[Epub ahead of print]
 
10) Merino AM, Greiner R, Hartwig K:A randomized controlled trial of a CPR decision support video for patients admitted to the General Medicine Service. J Hosp Med 12:700-704, 2017
 
11) Abolfotouh MA, Alnasser MA, Berhanu AN et al:Impact of basic life-support training on the attitudes of health-care workers toward cardiopulmonary resuscitation and defibrillation. BMC Health Serv Res 17:674, 2017
PubMed
12) Fordyce CB, Hansen CM, Kragholm K et al:Association of public health initiatives with outcomes for out-of-hospital cardiac arrest at home and in public locations. JAMA Cardiol, 2017[Epub ahead of print]
 
13) Debaty G, Labarere J, Frascone RJ et al:Long-term prognostic value of gasping during out-of-hospital cardiac arrest. J Am Coll Cardiol 70:1467-1476, 2017
PubMed
14) Yukawa T, Kashiura M, Sugiyama K et al:Neurological outcomes and duration from cardiac arrest to the initiation ofe xtracorporeal membrane oxygenation in patients with out-of-hospital cardiac arrest:a retrospective study. Scand J Trauma Resusc Emerg Med 25:95, 2017
 
15) Savastano S, Baldi E, Raimondi M et al:End-tidal carbon dioxide and defibrillation success in out-of-hospital cardiac arrest. Resuscitation, 2017 Sep 21[Epub ahead ofprint]
 
16) Eveson L, Vizcaychipi M, Patil S:Role of bispectral index monitoring and burst suppression in prognostication following out-of-hospital cardiac arrest:a systematic review protocol. Syst Rev 6:191, 2017
PubMed
17) Huang CH, Tsai MS, Ong HN et al:Association of hemodynamic variables with in-hospital mortality and favorable neurological outcomes in post-cardiac arrest care with targeted temperature management. Resuscitation, 2017 Jul 12[Epub ahead of print]
 
18) Mathias Stock, Christoph Testoria Fritz Sterza et al:Continuous versus intermittent neuromuscular blockade in patients during targeted temperature management after resuscitation from cardiac arrest-a randomized, double blinded, double dummy, clinical trial. Resuscitation 120:14-19, 2017[Epub ahead of print]
 
19) Salciccioli JD, Cocchi MN, Rittenberger JC et al:Continuous neuromuscular blockade is associated with decreased mortality in post-cardiac arrest patients. Resuscitation 84:1728-1733, 2013
PubMed
20) Dankiewicz J, Schmidbauer S, Nielsen N et al:Safety, feasibility, and outcomes of induced hypothermia therapy following in-hospital cardiac arrest-evaluation of a large prospective registry. Crit Care Med 42:2537-2545, 2014
PubMed
21) Zanyk-McLean K, Sawyer KN, Paternoster R et al:Time to awakening is often delayed in patients who receive targeted temperature management after cardiac arrest. Ther Hypothermia Temp Manag 7:95-100, 2017
PubMed
22) Nielsen AK, Jeppesen AN, Kirkegaard H et al:Changes in coagulation during therapeutic hypothermia in cardiac arrest patients. Resuscitation 98:85-90, 2016
PubMed
23) Jeppesen AN, Hvas AM, Duez CHV et al:Prolonged targeted temperature management compromises thrombin generation:a randomised clinical trial. Resuscitation, 2017 Jun 7[Epub ahead ofprint]
 
24) Kirkegaard H, Soreide E, de Haas I et al:Targeted temperature management for 48 vs 24 hours and neurologic outcome after out-of-hospital cardiac arrest:a randomized clinical trial. JAMA 318:341-350, 2017
PubMed
25) Aibiki M, Iwata O, Nonogi H et al:Board of directors of the Japanese Association of Brain Hypothermia. target temperature management for postcardiac arrest patients. Ther Hypothermia Temp Manag 4:104, 2014
 
26) Babini G, Grassi L, Russo I et al:Duration of untreated cardiac arrest and clinical relevance of animal experiments:the relationship between the "No-Flow"duration and the severity of post-cardiac arrest syndrome in a porcine model. Shock, 2017 May 30[Epub ahead of print]
 
27) Champigneulle B, Geri G, Bougouin W et al:Hypoxic hepatitis after out-of-hospital cardiac arrest:incidence, determinants and prognosis. Resuscitation 103:60-65, 2016
PubMed
28) Wada T, Gando S, Ono Y et al:Disseminated intravascular coagulation with the fibrinolytic phenotype predicts the outcome of patients with out-of-hospitalcardiac arrest. Thromb J 14:43, 2016
PubMed
29) Bro-Jeppesen J, Johansson PI, Kjaergaard J et al:Level of systemic inflammation and endothelial injury is associated with cardiovascular dysfunction and vasopressor support in post cardiac arrest patients. Resuscitation, 2017 Sep 23[Epub ahead of print]
 
30) Sugita A, Kinoshita K, Sakurai A et al:Systemic impact on secondary brain aggravation due to ischemia/reperfusion injury in post-cardiac arrest syndrome:a prospective observational study using high-mobility group box 1 protein. Crit Care 21:247, 2017
PubMed
31) Weiser C, Schwameis M, Sterz F et al:Mortality in patients resuscitated from out-of-hospital cardiac arrest based on automated blood cell count and neutrophil lymphocyte ratio at admission. Resuscitation 116:49-55, 2017
PubMed
32) Hoedemaekers CW, Ainslie PN, Hinssen S et al:Low cerebral blood flow after cardiac arrest is not associated with anaerobic cerebral metabolism. Resuscitation 120:45-50, 2017
 
33) Nagase M, Sakurai A, Sugita A et al:Oxidative stress and abnormal cholesterol metabolism in patients with post-cardiac arrest syndrome. J Clin Biochem Nutr 61:108-117, 2017
PubMed
34) Dale CM, Sinuff T, Morrison LJ et al:Understanding early decisions to withdraw life-sustaining therapy in cardiac arrest survivors. a qualitative investigation. Ann Am Thorac Soc 13:1115-1122, 2016
PubMed
35) Tamura T, Hayashida K, Sano M et al:Feasibility and safety of hydrogen gas inhalation for post-cardiac arrest syndrome. first-in-human pilot study. Circ J 80(8):1870-1873, 2016
PubMed
P.179 掲載の参考文献
1) Suzuki S, Yoshihisa A, Yamaki T et al:Acute heart failure volume control multicenter randomized (AVCMA) trial:comparison of tolvaptan and carperitide. J Clin Pharmacol 53:1277-1285, 2013
PubMed
2) Matsue Y, Suzuki M, Torii S et al:Clinical effectiveness of tolvaptan in patients with acute heart failure and renal dysfunction. J Card Fail 22:423-432, 2016
 
3) Kimura K, Momose T, Hasegawa T et al:Early administration of tolvaptan preserves renal function in elderly patients with acute decompensated heart failure. J Cardiol 67:399-405, 2016
PubMed
4) Jujo K, Saito K, Ishida I et al:Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure. ESC Heart Fail 3:177-188, 2016
PubMed
5) Tamaki S, Sato Y, Yamada T et al:Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure and preserved left ventricular ejection fraction:prospective randomized controlled study. Circ J 81:740-747, 2017
PubMed
6) Ambrosy AP, Pang PS, Khan S et al:Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduce dejection fraction:findings from the EVEREST trial. Eur Heart J 34:835-843, 2013
 
7) Inomata T, Ikeda Y, Kida K et al:Effects of additive tolvaptan vs. increased furosemide on heart failure with diuretic resistance and renal impairment-results from the K-STAR study. Circ J 82:159-167, 2017
 
8) Yancy CW, Jessup M, Bozkurt B et al:2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure:An update of the 2013 ACCF/AHA guideline for the management of heart failure:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol 68:1476-1488, 2016
 
9) 松崎益徳, 石井正浩, 和泉 徹他:循環器病の診断と治療に関するガイドライン(2009年度合同研究班報告)慢性心不全治療ガイドライン(2010年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2010_matsuzaki_h.pdf
 
10) Kotecha D, Chudasama R, Lane DA et al:Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction:a systematic review and meta-analysis of death and adverse outcomes. Int J Cardiol 203:660-666, 2016
PubMed
11) Xiong Q, Lau YC, Senoo K et al:Non-vitamin K antagonist oral anticoagulants(NOACs) in patients with concomitant atrial fibrillation and heart failure:a systemic review and meta-analysis of randomized trials. Eur J Heart Fail 17:1192-1200, 2015
PubMed
12) Koitabashi T, Inomata T, Niwano S et al:Paroxysmal atrial fibrillation coincident with cardiac decompensation is a predictor of poor prognosis in chronic heart failure. Circ J 69:823-830, 2005
PubMed
13) Aleong RG, Sauer WH, Davis G et al:New-onset atrial fibrillation predicts heart failure progression. Am J Med 127:963-971, 2014
PubMed
14) Guglin M, Chen R:How much atrial fibrillation causes symptoms of heart failure? Int J Clin Pract 68:453-457, 2014
PubMed
15) Roy D, Talajic M, Nattel S et al:Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358:2667-2677, 2008
PubMed
16) Steinberg BA, Zhao X, Heidenreich PA et al:Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction:prevalence, therapies, and outcomes. Circulation 126:65-75, 2012
PubMed
17) Owan TE, Hodge DO, Herges RM et al:Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251-259, 2006
PubMed
18) Grigorian Shamagian L, Gonzalez-Juanatey JR, Roman AV et al:The death rate among hospitalized heart failure patients with normal and depressed left ventricular ejection fraction in the year following discharge:evolution over a 10-year period. Eur Heart J 26:2251-2258, 2005
 
19) Yancy CW, Lopatin M, Stevenson LW et al:Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function:a report from the Acute Decompensated Heart Failure National Registry(ADHERE) Database. J Am Coll Cardiol 47:76-84, 2006
 
20) Fonarow GC, Stough WG, Abraham WT et al:Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure:a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 50:768-777, 2007
PubMed
21) Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S et al:Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology(JCARE-CARD). Circ J 73:1893-1900, 2009
PubMed
22) Tsuji K, Sakata Y, Nochioka K et al:Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study. Eur J Heart Fail, 2017 Mar 31[Epub ahead of print]
 
23) Lam CS, Teng TH:Understanding heart failure with mid-range ejection fraction. JACC Heart Fail 4:473-476, 2016
PubMed
24) Farmakis D, Simitsis P, Bistola V et al:Acute heart failure with mid-range left ventricular ejection fraction:clinical profile, in-hospital management, and short-term outcome. Clin Res Cardiol 106:359-368, 2017
PubMed
25) Solomon SD, Claggett B, Lewis EF et al:Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. Eur Heart J 37:455-462, 2016
PubMed
26) Hogg K, McMurray J:The treatment of heart failure with preserved ejection fraction("diastolic heart failure"). Heart Fail Rev 11:141-146, 2006
PubMed
27) Kapoor JR, Kapoor R, Ju C et al:Precipitating clinical factors, heart failure characterization, and outcomes in patients hospitalized with heart failure with reduced, borderline, and preserved ejection fraction. JACC Heart Fail 4:464-472, 2016
PubMed
28) Yu CM, Wang L, Chau E et al:Intrathoracic impedance monitoring in patients with heart failure:correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 112:841-848, 2005
PubMed
29) Chaudhry SI, Wang Y, Concato J et al:Patterns of weight change preceding hospitalization for heart failure. Circulation 116:1549-1554, 2007
PubMed
30) Abraham WT, Stevenson LW, Bourge RC et al:Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy:complete follow-up results from the CHAMPION randomised trial. Lancet 387:453-461, 2016
PubMed
P.184 掲載の参考文献
1) Niccoli G, Calvieri C, Flego D et al:Allergic inflammation is associated with coronary instability and a worse clinical outcome after acute myocardial infarction. Circ Cardiovasc Interv 8:e002554, 2015
 
2) Taniwaki M, Radu MD, Zaugg S et al:Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography. Circulation 133:650-660, 2016
PubMed
3) Shah AS, Anand A, Sandoval Y et al:High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome:a cohort study. Lancet 386:2481-2488, 2015
PubMed
4) Pickering JW, Greenslade JH, Cullen L et al:Assessment of the European Society of Cardiology 0-hour/1-hour algorithm to rule-out and rule-in acute myocardial infarction. Circulation 134:1532-1541, 2016
 
5) Jaffe AS, White H:Ruling-in myocardial injury and ruling-Out myocardial infarction with the European Society of Cardiology 1-hour algorithm. Circulation 134:1542-1545, 2016
 
6) Coskunpinar E, Cakmak HA, Kalkan AK et al:Circulating miR-221-3p as a novel marker for early prediction of acute myocardial infarction. Gene 591:90-96, 2016
PubMed
7) Dedic A, Ten Kate GJ, Roos CJ et al:Prognostic value of coronary computed tomography imaging in patients at high risk without symptoms of coronary artery disease. Am J Cardiol 117:768-774, 2016
PubMed
8) McNamara RL, Kennedy KF, Cohen DJ et al:Predicting in-hospital mortality in patients with acute myocardial infarction. J Am Coll Cardiol 68:626-635, 2016
PubMed
9) Hess PL, Wojdyla DM, Al-Khatib SM et al:Sudden cardiac death after non-ST-segment elevation acute coronary syndrome. JAMA Cardiol 1:73-79, 2016
PubMed
10) Hagstrom E, James SK, Bertilsson M et al:Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes:results from the PLATO study. Eur Heart J 37:1325-1333, 2016
PubMed
11) Bhatt DL, Stone GW, Mahaffey KW et al:Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med 368:1303-1313, 2013
PubMed
12) Gutierrez JA, Harrington RA, Blankenship JC et al:The effect of cangrelor and access site on ischaemic and bleeding events:insights from CHAMPION PHOENIX. Eur Heart J 37:1122-1130, 2016
PubMed
13) Meine TJ, Roe MT, Chen AY et al:Association of intravenous morphine use and outcomes in acute coronary syndromes:results from the CRUSADE Quality Improvement Initiative. Am Heart J 149:1043-1049, 2005
PubMed
14) Parodi G:Editor's choice-chest pain relief in patients with acute myocardial infarction. Eur Heart J Acute Cardiovasc Care 5:277-281, 2016
 
15) Kubica J, Adamski P, Ostrowska M et al:Morphine delays and attenuates ticagrelor exposure and action in patients with myo-cardial infarction:the randomized, double-blind, placebo-controlled IMPRESSION trial. Eur Heart J 37:245-252, 2016
 
16) Sahlen A, Varenhorst C, Lagerqvist B et al:Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction:experiences from SWEDEHEART registry. Eur Heart J 37:3335-3342, 2016
 
17) Wallentin L, Becker RC, Budaj A et al:Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045-1057, 2009
PubMed
18) Rollini F, Franchi F, Hu J et al:Crushed prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary intervention:the CRUSH study. J Am Coll Cardiol 67:1994-2004, 2016
PubMed
19) Udell JA, Bonaca MP, Collet JP et al:Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction:a collaborative meta-analysis of randomized trials. Eur Heart J 37:390-399, 2016
PubMed
20) Urban P, Meredith IT, Abizaid A et al:Polymer-free drug-coated coronary stents in patients at high bleeding risk. N Engl J Med 373:2038-2047, 2015
 
21) Naber CK, Urban P, Ong PJ et al:Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome:a Leaders Free ACS sub-study. Eur Heart J 38:961-969, 2017
PubMed
22) Stone GW, Witzenbichler B, Guagliumi G et al:Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 358:2218-2230, 2008
PubMed
23) Steg PG, van't Hof A, Hamm CW et al:Bivalirudin started during emergency transport for primary PCI. N Engl J Med 369:2207-2217, 2013
PubMed
24) Han Y, Guo J, Zheng Y et al:Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction:the BRIGHT randomized clinical trial. JAMA 313:1336-1346, 2015
PubMed
25) Shahzad A, Kemp I, Mars C et al:Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention(HEAT-PPCI):an open-label, single centre, randomised controlled trial. Lancet 384:1849-1858, 2014
PubMed
26) Sirker A, Mamas M, Robinson D et al:Bivalirudin, glycoprotein inhibitor, and heparin use and association with outcomes of primary percutaneous coronary intervention in the United Kingdom. Eur Heart J 37:1312-1320, 2016
PubMed
27) Garcia-Ruiz JM, Fernandez-Jimenez R, Garcia-Alvarez A et al:Impact of the timing of metoprolol administration during STEMI on infarct size and ventricular function. J Am Coll Cardiol 67:2093-2104, 2016
PubMed
28) Roolvink V, Ibanez B, Ottervanger JP et al:Early intravenous beta-blockers in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention. J Am Coll Cardiol 67:2705-2715, 2016
PubMed
29) Murphy SA, Cannon CP, Blazing MA et al:Reduction in total cardiovascular events with ezetimibe/simvastatin post-acute coronary syndrome:the IMPROVEIT trial. J Am Coll Cardiol 67:353-361, 2016
 
30) Stein EA, Gipe D, Bergeron J et al:Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy:a phase 2 randomised controlled trial. Lancet 380:29-36, 2012
PubMed
31) Sardella G, Lucisano L, Garbo R et al:Single-staged compared with multi-staged PCI in multivessel NSTEMI patients:the SMILE trial. J Am Coll Cardiol 67:264-272, 2016
 
32) Pyxaras SA, Hunziker L, Chieffo A et al:Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry:a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. EuroIntervention 12:e623-631, 2016
PubMed
33) Schoenenberger AW, Radovanovic D, Windecker S et al:Temporal trends in the treatment and outcomes of elderly patients with acute coronary syndrome. Eur Heart J 37:1304-1311, 2016
PubMed
34) Tegn N, Abdelnoor M, Aaberge L et al:Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris(After Eighty study):an open-label randomised controlled trial. Lancet 387:1057-1065, 2016
 
35) Mehta LS, Beckie TM, DeVon HA et al:Acute myocardial infarction in women:a scientific statement from the american heart association. Circulation 133:916-947, 2016
PubMed
36) Symons R, Masci PG, Francone M et al:Impact of active smoking on myocardial infarction severity in reperfused ST-segment elevation myocardial infarction patients:the smoker's paradox revisited. Eur Heart J 37:2756-2764, 2016
 
37) Luscher TF, Templin C:Is takotsubo syndrome a microvascular acute coronary syndrome? towards of a new definition. Eur Heart J 37:2816-2820, 2016
PubMed
38) Ahn JM, Lee KH, Yoo SY et al:Prognosis of variant angina manifesting as aborted sudden cardiac death. J Am Coll Cardiol 68:137-145, 2016
PubMed
P.193 掲載の参考文献
1) Sapp JL, Wells GA, Parkash R et al:Ventricular tachycardia ablation versus escalation of an tiarrhythmic drugs. N Engl J Med 375:111-21, 2016
PubMed
2) AbdelWahab A, Sapp J:Ventricular tachycardia with ICD shocks:when to medicate and when to ablate. Curr Cardiol Rep 19:105, 2017
 
3) Park KM, Nam GB, Choi KJ et al:Recurrent polymorphic ventricular tachycardia treated by ablation of purkinje arborization within an infarct border-zone. Tex Heart Inst J 38:291-294, 2011
PubMed
4) Murata H, Miyauchi Y, Hayashi M et al:Clinical and electrocardiographic characteristics of electrical storms due to monomorphic ventricular tachycardia refractory to intravenous amiodarone. Circ J 79:2130-2137, 2015
PubMed
5) January CT, Wann LS, Alpert JS et al:2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 64:e1-76, 2014
 
6) Nagai R, Kinugawa K, Inoue H et al:Urgent management of rapid heart rate in patients with atrial fibrillation /flutter and left ventricular dysfunction. comparison of the ultra-short-acting β1-selective blocker lndiolol with digoxin(J-Land study) Circ J 2013;77;908-916
 
7) 井上 博, 新 博次, 奥村 譲他:心房細動治療(薬物)ガイドライン(2013年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2013_inoue_h.pdf
 
8) 上原裕規, 山下慶子, 名護元志 他:心機能低下例における頻脈性不整脈(心房細動・粗動)に対する短時間作用型β遮断薬ランジオロールの使用経験. Prog Med 34:1805-1809, 2014
Medical*Online
9) 川瀬裕一, 門田一繁, 畑 玲央 他:当院における頻脈性心房細動・粗動に対する短時間作用型β遮断薬ランジオロールの使用経験. Prog Med 35:1203-1209, 2015
Medical*Online
10) Sezai A, Minami K, Nakai T et al:Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting:new evi dence from the PASCAL trial. J Thorac Cardiovasc Surg 141:1478-1487, 2011
 
11) Li L, Ai Q, Lin L:Efficacy and safety of landiolol for prevention of atrial fibrillation after cardiac surgery:a meta-analysis of randomized controlled trials. Int J Clin Exp Med 8:10265-10273, 2015
PubMed
12) Ji T, Feng C, Sun L et al:Are beta-blockers effective for preventing postcoronary artery bypass grafting atrial fibrillation? direct and network meta-analyses. Ir J Med Sci 185:503-511, 2016
PubMed
13) Bristow MR, Saxon LA, Boehmer J et al:Cardiac- resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140-2150, 2004
 
14) Cleland JG, Daubert JC, Erdmann E et al:The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539-1549, 2005
PubMed
15) Bristow MR, Saxon LA, Boehmer J et al:Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Eng J Med 350:2140-2150, 2004
 
16) Barra S, Providencia R, Tang A et al:Importance of implantable cardioverter-defibrillator back-up in cardiac resynchronization therapy recipients:a systematicreview and meta-analysis. J Am Heart Assoc, 2015 Nov 6[Epub ahead of print]
 
17) Gold MR, Padhiar A, Mealing S et al:Long-term extrapolation of clinical benefits among patients with mild heart failure receiving cardiac resynchronization therapy:analysis of the 5-year follow-up from the REVERSE study. JACC Heart Fail 3:691-700, 2015
PubMed
18) Woods B, Hawkins N, Mealing S et al:Individual patient data network meta-analysis of mortality effects of implantable cardiac devices. Heart 101:1800-1806, 2015
PubMed
19) Gold MR, Padhiar A, Mealing S et al:Long-term extrapolation of clinical benefits among patients with mild heart failure receiving cardiac resynchronization therapy:analysis of the 5-year follow-up from the REVERSE study. JACC HEART FAIL 3:691-700, 2015
PubMed
20) Yokoshiki H, Shimizu A, Mitsuhashi T et al:Survival and heart failure hospitalization in patients with cardiac resynchronization therapy with or without a defibrillator for primary prevention in Japan:analysis of the Japan cardiac device treatment registry database. Circ J, 2017 Jun 13[Epub ahead of print]
 
21) Udo EO, Zuithoff NP, van Hemel NM et al:Incidence and predictors of short-and long-term complications in pacemak er therapy:the FOLLOWPACE study. Heart Rhythm 9:728-735, 2012
 
22) Reynolds D, Duray GZ, Omar R et al:A leadless intracardiac transcatheter pacing system. N Engl J Med 374:533-541, 2016
 
23) Duray GZ, Ritter P, El-Chami M et al:Long-term performance of a transcatheter pacing system:12-Month results from the Micra transcatheter pacing study. Heart Rhythm 14:702-709, 2017
PubMed
24) Soejima K, Taku Asano T, Ishikawa T et al:Performance of leadless pacemaker in Japanese patients vs. rest of the world-results from a global clinical trial-Circ J, 2017 May 30[Epub ahead of print]
 
P.198 掲載の参考文献
1) Singer M, Deutschman CS, Seymour CW et al:The third international consensus definitions for sepsis and septic shock(Sepsis-3). JAMA 315:801-810, 2016
PubMed
2) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference:Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992
PubMed
3) 日本版敗血症診療ガイドライン2016. http://www.jsicm.org/pdf/jjsicm24Suppl2-2.pdf
 
4) Simpson SQ:SIRS in the time of sepsis-3. Chest, 2017 Oct 14[Epub ahead of print]
 
5) Ranzani OT, Torres A:Reply to:Sepsis-3 in community-acquired pneumonia:how reliable is it? Am J Respir Crit Care Med, 2017 Sep 11[Epub ahead of print]
 
6) Schmoch T, Bernhard M, Uhle F et al:New sepsis-3 definition:do we have to treat sepsis before we can diagnose it from now on? Anaesthesist 66:614-621, 2017
PubMed
7) Carneiro AH, Povoa P, Gomes JA:Dear sepsis-3, we are sorry to say that we don't like you. Rev Bras Ter Intensiva 29:4-8, 2017
 
8) Fang X, Wang Z, Yang J et al:Clinical evaluation of sepsis-1 and sepsis-3 in the ICU. Chest, 2017 Jul 12[Epub ahead ofprint]
 
9) Kaukonen KM, Bailey M, Pilcher D et al:Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med 372:1629-1638, 2015
PubMed
10) Peake SL, Delaney A, Bailey M et al;ARISE Investigators:Potential impact of the 2016 consensus definitions of sepsis and septic shock on future sepsis research. Ann Emerg Med 70:553-561, 2017
PubMed
11) Sterling SA, Puskarich MA, Glass AF et al:The impact of the sepsis-3 septic shock definition on previously defined septic shock patients. Crit Care Med 45:1436-1442, 2017
PubMed
12) Amland RC, Sutariya BB:Quick Sequential[Sepsis-Related] Organ Failure Assessment(qSOFA)and St. John Sepsis Surveillance Agent to detect patients at risk of sepsis:an observational cohort study. Am J Med Qual 1062860617692034, 2017 Feb 1[Epub ahead of print]
 
13) Donnelly JP, Safford MM, Shapiro NI et al:Application of the third international consensus definitions for sepsis(Sepsis-3)classification:a retrospective population-based cohort study. Lancet Infect Dis 17:661-670, 2017
PubMed
14) French Society of Emergency Medicine Collaborators Group:Prognostic accuracy of sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department. JAMA 317:301-308, 2017
 
15) Australian and New Zealand Intensive Care Society(ANZICS)Centre for Outcomes and Resource Evaluation(CORE):Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA 317:290-300, 2017
 
16) SepNet Critical Care Trials Group:Incidence of severe sepsis and septic shock in German intensive care units:the prospective, multicentre INSEP study. Intensive Care Med 42:1980-1989, 2016
 
17) Piano S, Bartoletti M, Tonon M et al:Assessment of sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections. Gut, 2017 Aug 31[Epub ahead of print]
 
18) Levy MM, Fink MP, Marshall JC et al:2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 31:1250-1256, 2003
PubMed
19) Williams JM, Greenslade JH, McKenzie JV et al:Systemic inflammatory response syndrome, quick sequential organ function assessment, and organ dysfunction:insights from a prospective database of ED patients with infection. Chest 151:586-596, 2017
PubMed
20) Shankar-Hari M, Harrison DA, Rubenfeld GD et al:Epidemiology of sepsis and septic shock in critical care units:comparison between sepsis-2 and sepsis-3 populations using a national critical care database. Br J Anaesth 119:626-636, 2017
PubMed
21) Stevenson EK, Rubenstein AR, Radin GT et al:Two decades of mortality trends among patients with severe sepsis:a comparative meta-analysis. Crit Care Med 42:625-631, 2014
PubMed
22) Shin TG, Hwang SY, Kang GH et al:Korean Shock Society septic shock registry:a preliminary report. Clin Exp Emerg Med 4:146-153, 2017
PubMed
23) Lee CC, Yo CH, Lee MG et al:Adult sepsis-A nationwide study of trends and outcomes in a population of 23 million people. J Infect 75:409-419, 2017
 
24) Leisman DE, Doerfler ME, Schneider SM et al:Predictors, prevalence, and outcomes of early crystalloid responsiveness among initially hypotensive patients with sepsis and septic shock. Crit Care Med, 2017 Nov 3[Epub ahead of print]
 
25) Pruinelli L, Westra BL, Yadav P et al:Delay within the 3-hour surviving sepsis campaign guideline on mortality for patients with severe sepsis and septic shock. Crit Care Med, 2018 Jan 2[Epub ahead of print]
 
26) Dellinger RP, Levy MM, Rhodes A et al:Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock, 2012. Crit Care Med 41:580-637, 2013
PubMed
27) Oh DH, Kim MH, Jeong WY et al:Risk factors for mortality in patients with low lactate level and septic shock. J Microbiol Immunol Infect, 2017 Aug 26[Epub ahead of print]
 
28) Driessen RGH, van de Poll MCG, Mol MF et al:The influence of a change in septic shock definitions on intensive care epidemiology and outcome:comparison of sepsis-2 and sepsis-3 definitions. Infect Dis(Lond)26:1-7, 2017
PubMed
29) Tarui T, Yamaguchi Y, Suzuki K et al:Early evaluation of severity in patients with severe sepsis:a comparison with "septic shock" -subgroup analysis of the Japanese Association for Acute Medicine Sepsis Registry(JAAM-SR). Acute Med Surg 4:426-431, 2017
PubMed
30) JAAM Sepsis Registry(JAAMSR)Study Group:Assessment of mortality by qSOFA in patients with sepsis outside ICU:a post hoc subgroup analysis by the Japanese Association for Acute Medicine Sepsis Registry Study Group. J Infect Chemother 23:757-762, 2017
 
31) ALBIOS Biomarkers Study Investigators:Pentraxin 3 in patients with severe sepsis or shock:the ALBIOS trial. Eur J Clin Invest 47:73-83, 2017
PubMed
32) Hamed S, Behnes M, Pauly D et al:Diagnostic value of Pentraxin-3 in patients with sepsis and septic shock in accordance with latest sepsis-3 definitions. BMC Infect Dis 17:554, 2017
PubMed
33) Jie H, Li Y, Pu X et al:Pentraxin 3, a predicator for 28-day mortality in patientswith septic shock.Am J Med Sci 353:242-246, 2017
 
34) Liu SY, Zhang L, Zhang Y et al:Bioinformatic analysis of pivotal genes associated with septic shock. J Biol Regul Homeost Agents 31:935-941, 2017
 
35) Katip W, Jaruratanasirikul S, Pattharachayakul S et al:The pharmacokinetics of vancomycin during the initial loading dose in patients with septic shock. Infect Drug Resist 9:253-260, 2016
PubMed
36) Sjovall F, Alobaid AS, Wallis SC et al:Maximally effective dosing regimens of meropenem in patients with septic shock. J Antimicrob Chemother 73:191-198, 2018
PubMed
37) Sherwin R, Winters ME, Vilke GM et al:Does early and appropriate antibiotic administration improve mortality in emergency department patients with severe sepsis or septic shock? J Emerg Med 53:588-595, 2017
PubMed
38) Laine ME, Flynn JD, Flannery AH:Impact of pharmacist intervention on selection and timing of appropriate antimicrobial therapy in septic shock. J Pharm Pract, 897190017696953, 2017 Mar 15[Epub ahead of print]
 
39) Asfar P, Meziani F, Hamel JF et al:High versus low blood-pressure target in patients with septic shock. N Engl J Med 370:1583-1593, 2014
PubMed
40) Lamontagne F, Meade MO, Hebert PC et al:Higher versus lower blood pressure targets for vasopressor therapy in shock:a multicenter pilot randomized controlled trial. Intensive Care Med 42:542-550, 2016
 
41) Lamontagne F, Day AG, Meade MO et al:Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock. Intensive Care Med, 2017 Dec 19[Epub ahead of print]
 
42) Khanna A, English SW, Wang XS et al:Angiotensin II for the treatment of vasodilatory shock. N Engl J Med 377:419-430, 2017
 
43) VANISH Investigators:Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock:The VANISH randomized clinical trial. JAMA 316:509-518, 2016
PubMed
44) Russell JA, Vincent JL, Kjolbye AL et al:Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients. Crit Care 21:213, 2017
 
45) Vallabhajosyula S, Kumar M, Pandompatam G et al:Prognostic impact of isolated right ventricular dysfunction in sepsis and septic shock:an 8-year historical cohort study. Ann Intensive Care 7:94, 2017
PubMed
46) Fuchs C, Wauschkuhn S, Scheer C et al:Continuing chronic beta-blockade in the acute phase of severe sepsis and septic shock is associated with decreased mortality rates up to 90 days. Br J Anaesth 119:616-625, 2017
PubMed
47) Liu P, Wu Q, Tang Y et al:The influence of esmolol on septic shock and sepsis:a meta-analysis of randomized controlled studies. Am J Emerg Med, 2017 Nov 8[Epub ahead of print]
 
48) Wang B, Chen R, Guo X et al:Effects of levosimendan on mortality in patients with septic shock:systematic review with meta-analysis and trial sequential analysis. Oncotarget 8:100524-100532, 2017
 
49) PRISM Investigators, Rowan KM, Angus DC et al:Early, goal-directed therapy for septic shock-a patient-level meta-analysis. N Engl J Med 376:2223-2234, 2017
PubMed
50) Marik PE, Linde-Zwirble WT, Bittner EA et al:Fluid administration in severe sepsis and septic shock, patterns and outcomes:an analysis of a large national database. Intensive Care Med 43:625-632, 2017
PubMed
51) Leisman DE, Goldman C, Doerfler ME et al:Patterns and outcomes associated with timeliness of initial crystalloid resuscitation in a prospective sepsis and septic shock cohort. Crit Care Med 45:1596-1606, 2017
 
52) HYPER2S Investigators;REVA research network:Hyperoxia and hypertonic saline in patients with septic shock(HYPERS2S):a two-by-two factorial, multicentre, randomised, clinical trial. Lancet Respir Med 5:180-190, 2017
 
53) UTCOMEREA Study Group:Effect of transfusion on mortality and other adverse events among critically ill septic patients:an observational study using a marginal structural cox model. Crit Care Med 45:1972-1980, 2017
 
P.207 掲載の参考文献
1) Turnbull AE, Rabiee A, Davis WE et al:Outcome measurement in ICU survivorship research from 1970 to 2013:a scoping review of 425 publications. Crit Care Med 44:1267-1277, 2016
PubMed
2) Yende S, Austin S, Rhodes A et al:Long-term quality of life among survivors of severe sepsis:analyses of two international trials. Crit Care Med 44:1461-1467, 2016
PubMed
3) Guirgis FW, Brakenridge S, Sutchu S et al:The long-term burden of severe sepsis and septic shock:sepsis recidivism and organ dysfunction. J Trauma Acute Care Surg 81:525-532, 2016
 
4) Dettling-Ihnenfeldt DS, Wieske L, Horn J et al:Functional recovery in patients with and without intensive care unit-acquired weakness. Am J Phys Med Rehabil 96:236-242, 2017
PubMed
5) Wieske L, Verhamme C, Witteveen E et al:Feasibility and diagnostic accuracy of early electrophysiological recordings for ICU-acquired weakness:an observational cohort study. Neurocrit Care 22:385-394, 2015
PubMed
6) Nikayin S, Rabiee A, Hashem MD et al:Anxiety symptoms in survivors of critical illness:a systematic review and meta-analysis. Gen Hosp Psychiatry 43:23-29, 2016
PubMed
7) Rabiee A, Nikayin S, Hashem MD et al:Depressive symptoms after critical illness:a systematic review and meta-analysis. Crit Care Med 44:1744-1753, 2016
PubMed
8) Parker AM, Sricharoenchai T, Raparla S et al:Posttraumatic stress disorder in critical illness survivors:a metaanalysis. Crit Care Med 43:1121-1129, 2015
PubMed
9) Huang M, Parker AM, Bienvenu OJ et al:Psychiatric symptoms in acute respiratory distress syndrome survivors:a 1-year national multicenter study. Crit Care Med 44:954-965, 2016
PubMed
10) Wolters AE, Peelen LM, Welling MC et al:Long-term mental health problems after delirium in the ICU. Crit Care Med 44:1808-1813, 2016
PubMed
11) Bienvenu OJ, Colantuoni E, Mendez-Tellez PA et al:Cooccurrence of and remission from general anxiety, depression, and posttraumatic stress disorder symptoms after acute lung injury:a 2-year longitudinal study. Crit Care Med 43:642-653, 2015
PubMed
12) Petrinec A:Post-intensive care syndrome in family decision makers of long-term acute care hospital patients. Am J Crit Care 26:416-422, 2017
PubMed
13) Brown SM, Wilson E, Presson AP et al:Predictors of 6-month health utility outcomes in survivors of acute respiratory distress syndrome. Thorax 72:311-317, 2017
PubMed
14) Dinglas VD, Hopkins RO, Wozniak AW et al:One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome:prospective follow-up of SAILS randomised trial. Thorax 71:401-410, 2016
PubMed
15) Rygard SL, Holst LB, Wetterslev J et al:Long-term outcomes in patients with septic shock transfused at a lower versus a higher haemoglobin threshold:the TRISS randomised, multicentre clinical trial. Intensive Care Med 42:1685-1694, 2016
 
16) Asfar P, Schortgen F, Boisrame-Helms J et al:Hyperoxia and hypertonic saline in patients with septic shock(HYPERS2S):a two-by-two factorial, multicentre, randomised, clinical trial. Lancet Respir Med 5:180-190, 2017
PubMed
17) Madsen MB, Hjortrup PB, Hansen MB et al:Immunoglobulin G for patients with necrotising soft tissue infection(INSTINCT):a randomised, blinded, placebo-controlled trial. Intensive Care Med 43:1585-1593, 2017
PubMed
18) Shepherd SJ, Newman R, Brett SJ et al:Pharmacological therapy for the prevention and treatment of weakness after critical illness:a systematic review. Crit Care Med 44:1198-1205, 2016
PubMed
19) Shelly AG, Prabhu NS, Jirange P et al:Quality of life improves with individualized home-based exercises in critical care survivors. Indian J Crit Care Med 21:89-93, 2017
PubMed
20) McDowell K, O'Neill B, Blackwood B et al:Effectiveness of an exercise programme on physical function in patients discharged from hospital following critical illness:a randomised controlled trial(the REVIVE trial). Thorax 72:594-595, 2017
PubMed
21) Kayambu G, Boots R, Paratz J:Early physical rehabilitation in intensive care patients with sepsis syndromes:a pilot randomised controlled trial. Intensive Care Med 41:865-874, 2015
PubMed
22) Morris PE, Berry MJ, Files DC, et al:Standardized rehabilitation and hospital length of stay among patients with acute respiratory failure:a randomized clinical trial. JAMA 315:2694-2702, 2016
PubMed
23) McWilliams DJ, Benington S, Atkinson D:Outpatient-based physical rehabilitation for survivors of prolonged critical illness:a randomized controlled trial. Physiother Theory Pract 32:179-190, 2016
PubMed
24) Moss M, Nordon-Craft A, Malone D et al:A randomized trial of an intensive physical therapy program for patients with acute respiratory failure. Am J Respir Crit Care Med 193:1101-1110, 2016
 
25) Schmidt K, Worrack S, Von Korff M et al:Effect of a primary care management intervention on mental health-related quality of life among survivors of sepsis:a randomized clinical trial. JAMA 315:2703-2711, 2016
PubMed
26) Ullman AJ, Aitken LM, Rattray J et al:Intensive care diaries to promote recovery for patients and families after critical illness:cochrane systematic review. Int J Nurs Stud 52:1243-1253, 2015
PubMed
27) 日本版敗血症診療ガイドライン2016作成特別委員会:日本版敗血症診療ガイドライン2016. 日集中医誌 24:S1-S232, 2017
 
28) 日本集中治療医学会早期リハビリテーション検討委員会:集中治療における早期リハビリテーション～根拠に基づくエキスパートコンセンサス～. 日集中医誌 24:255-303, 2017
 
29) Rhodes A, Evans LE, Alhazzani W et al:Surviving Sepsis Campaign:international guidelines for management of sepsis and septic shock:2016. Intensive Care Med 43:304-377, 2017
PubMed

IV章 トピックス

P.215 掲載の参考文献
1) Krinsley JS, Wasser T, Kang G et al:Preadmission functional status impacts the performance of the APACHE IV model of mortality prediction in critically ill patients. Critical Care 21:110, 2016
 
2) Kramer AA, Higgins TL, Zimmerman JE et al:Comparing observed and predicted mortality among ICUs Using different prognostic systems:why do performance assessments differ?:Crit Care Med 43:261-269, 2015
PubMed
3) Williams JM, Greenslade JH, Chu K et al:Severity scores in emergency department patients with presumed infection:a prospective validation study. Crit Care Med 44:539-547, 2016
PubMed
4) Ryan HM, Sharma S, Magee LA et al:The usefulness of the APACHE II score in obstetric critical care:a structured review. J Obstet Gynaecol Can 38:909-918, 2016
PubMed
5) Vasquez DN, Das Neves AV, Vidal L et al:Characteristics, outcomes, and predictability of critically ill obstetric patients:a multicenter prospective cohort study. Crit Care Med 43:1887-1897, 2015
PubMed
6) Aarvold AB, Ryan HM, Magee LA et al:Multiple organ dysfunction score is superior to the obstetric-specific sepsis in obstetrics score in predicting mortality in septic obstetric patients. Crit Care Med 45:e49-e57, 2017
 
7) Albright CM, Ali TN, Lopes V et al:The sepsis in obstetrics score:a model to identify risk of morbidity from sepsis in pregnancy. Am J Obstet Gynecol 211:39. e1-39. e8, 2014
 
8) Engerstrom L, Kramer AA, Nolin T et al:Comparing time-fixed mortality prediction models and their effect on ICU performance metrics using the simplified acute physiology score 3. Crit Care Med 44:e1038-e1044, 2016
PubMed
9) Poncet A, Perneger TV, Merlani P et al:Determinants of the calibration of SAPS II and SAPS 3 mortality scores in intensive care:a European multicenter study. Crit Care 21:85, 2017
PubMed
10) Singer M, Deutschman CS, Seymour CW et al:The third international consensus definitions for sepsis and septic Shock(Sepsis-3). JAMA 315:801-810, 2016
PubMed
11) Seymour CW, Liu VX, Iwashyna TJ et al:Assessment of clinical criteria for sepsis:for the third international consensus definitions for sepsis and septic shock(Sepsis-3). JAMA 315:762-774, 2016
PubMed
12) Sterling SA, Puskarich MA, Glass AF et al:The impact of the Sepsis-3 septic shock definition on previously defined septic shock patients. Crit Care Med 45:1436-1442, 2017
PubMed
13) Williams JM, Greenslade JH, McKenzie JV et al:Systemic inflammatory response syndrome, quick sequential organ function assessment, and organ dysfunction:insights from a prospective database of ED patients with infection. Chest 151:586-596, 2017
PubMed
14) Moskowitz A, Patel PV, Grossestreuer AV, et al:Quick sequential organ failure assessment and systemic inflammatory response syndrome criteria as predictors of critical care intervention among patients with suspected infection. Crit Care Med 45:1813-1819, 2017
PubMed
15) Freund Y, Lemachatti N, Krastinova E et al:Prognostic accuracy of Sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department. JAMA 317:301-308, 2017
 
16) Raith EP, Udy AA, Bailey M et al:Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA 317:290-300, 2017
 
17) Finkelsztein EJ, Jones DS, Ma KC et al:Comparison of qSOFA and SIRS for predicting adverse outcomes of patients with suspicion of sepsis outside the intensive care unit. Crit Care 21:73, 2017
PubMed
18) Wang HE, Jones AR, Donnelly JP et al:Revised national estimates of emergency department visits for sepsis in the United States. Crit Care Med 45:1443-1449, 2017
PubMed
19) de Grooth HJ, Geenen IL, Girbes AR et al:SOFA and mortality endpoints in randomized controlled trials:a systematic review and meta-regression analysis. Crit Care 21:38, 2017
PubMed
20) https://www.rcplondon.ac.uk/projects/outputs/national-early-warning-scorenews
 
21) Smith ME, Chiovaro JC, O'Neil M et al:Early warning system scores for clinical deterioration in hospitalized patients:a systematic review. Ann Am Thorac Soc 11:1454-1465, 2014
PubMed
22) Churpek MM, Snyder A, Han X et al:Quick sepsis-related organ failure assessment, systemic inflammatory response syndrome, and early warning scores for detecting clinical deterioration in infected patients outside the intensive care unit. Am J Respir Crit Care Med 195:906-911, 2017
PubMed
23) Churpek MM, Snyder A, Sokol S et al:Investigating the impact of different suspicion of infection criteria on the accuracy of quick sepsis-related organ failure assessment, systemic inflammatory response syndrome, and early warning scores. Crit Care Med 45:1805-1812, 2017
PubMed
24) Alam N, Vegting IL, Houben E et al:Exploring the performance of the National Early Warning Score(NEWS)in a European emergency department. Resuscitation 90:111-115, 2015
 
25) Liu V:Keeping score of severity scores:taking the next step. Crit Care Med 44:639-640, 2016
PubMed
P.221 掲載の参考文献
1) Smith GB, Prytherch DR, Jarvis S et al:A comparison of the ability of the physiologic components of medical emergency team criteria and the U.K. national early warning score to discriminate patients at risk of a range of adverse clinical outcomes. Crit Care Med 44:2171-2181, 2016
 
2) Nishijima I, Oyadomari S, Maedomari S et al:Use of a modified early warning score system to reduce the rate of in-hospital cardiac arrest. J Intensive Care 4:12, 2016
PubMed
3) Douw G, Huisman-de Waal G, van Zanten ARH et al:Capturing early signs of deterioration:the dutch-early-nurse-worry-indicator-score and its value in the rapid response system. J Clin Nurs 26:2605-2613, 2017
PubMed
4) Bellew SD, Cabrera D, Lohse CM et al:Predicting early rapid response team activation in patients admitted from the emergency department:the PeRRT score. Acad Emerg Med 24:216-225, 2017
PubMed
5) Moskowitz A, Andersen LW, Karlsson M et al:Predicting in-hospital mortality for initial survivors of acute respiratory compromise(ARC) events:development and validation of the ARC score. Resuscitation 115:5-10, 2017
PubMed
6) Subbe CP, Duller B, Bellomo R:Effect of an automated notification system for deteriorating ward patients on clinical outcomes. Crit Care 21:52, 2017
PubMed
7) Lee YJ, Lee DS, Min H et al:Differences in the clinical characteristics of rapid response system activation in patients admitted to medical or surgical services. J Korean Med Sci 32:688-694, 2017
PubMed
8) Paternina-Caicedo A, Miranda J, Bourjeily G et al:Performance of the obstetric early warning score in critically ill patients for the prediction of maternal death. Am J Obstet Gynecol 216:58. e1-58. e8, 2017
 
9) Chen J, Bellomo R, Flabouris A et al:Delayed emergency team calls and associated hospital mortality:a multicenter study. Crit Care Med 43:2059-2065, 2015
PubMed
10) White K, Scott IA, Bernard A et al:Patient characteristics, interventions and outcomes of 1151 rapid response team activations in a tertiary hospital:a prospective study. Intern Med J 46:1398-1406, 2016
 
11) Brunsveld-Reinders AH, Ludikhuize J, Dijkgraaf MG et al:Unexpected versus all-cause mortality as the endpoint for investigating the effects of a Rapid Response System in hospitalized patients. Crit Care 20:168, 2016
PubMed
12) Cardona-Morrell M, Chapman A, Turner RM et al:Pre-existing risk factors for in-hospital death among older patients could be used to initiate end-of-life discussions rather than rapid response system calls:a case-control study. Resuscitation 109;76-80, 2016
 
13) Maharaj R, Raffaele I, Wendon J:Rapid response systems:a systematic review and meta-analysis. Crit Care 19:254, 2015
 
14) Ludikhuize J, Brunsveld-Reinders AH, Dijkgraaf MG et al:Outcomes associated with the nationwide introduction of rapid response systems in the Netherlands. Crit Care Med 43:2544-2551, 2015
PubMed
15) Chen J, Ou L, Flabouris A et al:Impact of a standardized rapid response system on outcomes in a large healthcare jurisdiction. Resuscitation 107:47-56, 2016
 
16) Rihari-Thomas J, DiGiacomo M, Phillips J et al:Clinician perspectives of barriers to effective implementation of a rapid response system in an academic health centre:a focus group study. Int J Health Policy Manag 6:447-456, 2017
 
17) Subramaniam A, Botha J, Tiruvoipati R:The limitations in implementing and operating a rapid response system. Intern Med J 46:1139-1145, 2016
PubMed
18) Murphy A, Cronin J, Whelan R et al:Economics of early warning scores for identifying clinical deterioration-a systematic review. Ir J Med Sci, 2017 Jun 3[Epub ahead of print]
 
19) 谷島雅子, 阿野正樹, 鈴川正之:RRS(rapid response system)を活用した, 院内急変時対応の部署別教育. 日臨救医誌 18:506-511, 2015
 
20) 児玉貴光:聖マリアンナ医科大学病院におけるRapid Response System導入の軌跡. 蘇生 35:1-5, 2016
Medical*Online
21) 武居哲洋, 和智万由子, 三上久美子:Rapid Response Systemに準じた拡大コードシステム導入の効果. 日赤医学 66:415-419, 2015
 
22) 特集・Rapid Response Systemをめぐって. ICUとCCU 40:251-291, 2016
 
23) 日本集中治療医学会/日本臨床救急医学会Rapid Response System合同委員会, 日本集中治療医学会Rapid Response System検討委員会:Rapid Response Systemに関わる用語の日本語訳と定義. 日集中医誌 24:355-360, 2017
 

書評

最近チェックした商品履歴

Loading...